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Obstructive sleep apnea syndrome (OSAS) is a global problem and its 
prevalence has been estimated to be around 3-4 % in adults and 1 -4% in children. 
For adults, there is overwhelming evidence to suggest OSAS as an independent risk 
factor for various cardiovascular diseases such as hypertension and congestive heart 
failure. However, similar data is lacking for the paediatric population and the few 
published studies are limited by their small sample size and the lack of normal 
healthy subjects for comparison. 
In this study, we aimed to compare (1) ambulatory blood pressure, and (2) 
cardiac dimensions and function of children suffering from OSAS with normal 
healthy children. 
The cases of this project were recruited from the community. Parents of primary 
school children randomly chosen from three districts were asked to fill in a validated 
questionnaire and those screened to be at high risk for OSAS were invited for 
overnight sleep study. Those screened to be at low risk for OSAS were recruited as 
controls. 
Our results showed that children with more severe OSAS as reflected by higher 
apnea-hypopnea index (AHI) had higher awake systolic {p < 0.0001) and diastolic {p 
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< 0.001), sleep systolic {p < 0.0001) and diastolic (p = 0.003) blood pressure 
compared to children with milder disease and those without OS AS. In addition, it 
was found that subjects with an AHI > 5 had a significantly higher risk to have 
nocturnal systolic hypertension (OR = 3.883; 95% CI: 1.434 — 10.512) and nocturnal 
diastolic hypertension (OR = 3.309; 95% CI: 1.355 — 8.085) when compared to 
healthy controls. 
The second part of our study demonstrated significant impaired right ventricular 
(RV) function in children with OSAS as reflected by larger RV systolic volume index 
to height (RVSVI, p < 0.001), worse RV ejection fraction (RVEF, p = 0.001) and 
higher RV myocardial performance index (RVMPI, p < 0.001). We also showed 
significant impaired left ventricular (LV) diastolic function in children with AHI > 5 
as reflected by the ratio of transmitral pulse Doppler velocity over septal annular 
regional early diastolic tissue velocity (E/e', p = 0.009), and also significant LV 
remodeling with larger interventricular wall thickness index to height (IVSI, p = 
0.004) and greater relative wall thickness (RWT, p = 0.005). Furthermore, a 
significantly higher proportion of this group was also documented to have abnormal 
LV geometry (p < 0.001). After treatment for OSAS, there were improvements in 
RVMPI (p = 0.005), LV mass index to height:" (LVMI, p = 0.038), IVSI (p = 0.019) 
and E/e，（/? = 0.018). 
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Our study consolidated the hypothesis that cardiovascular complications are 
also prevalent in children with OSAS. We provided evidence that OSAS is an 
independent risk factor for hypertension in children, and the condition also causes 















健康的兒童有較高的日間收縮壓（P < 0.0001)和舒張壓（/7 < 0.001)，以及較高 
的夜間收縮壓 (p< 0.0001)和舒張壓(P 二 0.003)�此外’結果亦顯示呼吸暫停低 
通氣指數大於5的兒童患有夜間收縮期高血壓（OR 二 3.883; 95% CI: 1.434 -






數（RVSVI,/7<0.001)�較低的右心室射血分數（RVEF,/7 = 0.001)和較高的心 
肌功能綜合指數（RVMPI,;7 < 0.001) ’反映他們的右心室功能較差°此外，數 
據亦顯示呼吸暫停低通氣指數大於5的兒童的二尖瓣快速充盈期脈衝多普勒流 
速/室壁快速充盈期心肌多普勒運動速度的比率（E/e’,/7 = 0.009)較高’反映 
他們的左心室（LV )舒張功能較差°另外，他們的室間隔厚度指數（IVSI, P = 
0.004)及相對室壁厚度（RWT,;7 = 0.005)也較大。同時在比例上他們較多患有 
在心室形態異常 < 0.001 )�經治療後’兒童OSAS患者的RVMPK;? = 0.005 ) � 
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Overview of Childhood OSAS 1 
CHAPTER 1 
Overview of Childhood 
Obstructive Sleep Apnea Syndrome (OSAS) 
1.1 Clinical Features of Childhood OSAS 
Childhood OSAS is a disorder of breathing during sleep characterised by 
prolonged increased upper airway resistance, partial upper airway obstruction, or 
complete obstruction that disrupts pulmonary ventilation and oxygenation (American 
Academy of Pediatrics, 2002). Snoring is the most common feature of childhood 
OSAS although children with severe OSAS may have minimal snoring. Witnessed 
apnea is another major sign of OSAS. Others possible important symptoms include 
mouth breathing and excessive sweating during sleep, and increased respiratory 
efforts leading to paradoxical respiratory movement, which should be considered as 
abnormal after 3 years of age (Traeger N. et al., 2005). It was suggested that 
nocturnal enuresis is a symptom of childhood OSAS (Ng DK. et al., 2001). Although 
a case-control study showed that there was no difference in incidence of nocturnal 
enuresis between OSAS group and control group (Brouilette R. et al., 1984), another 
study demonstrated that treatment of OSAS with T&A reduced the incidence of 
11 
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nocturnal enuresis (Ng DK. et al., 2001). Excessive daytime sleepiness (EDS) is 
uncommon in children with OSAS, probably because children with OSAS have 
normal sleep architecture (Goh DY. et al,, 2000). Another explanation is the 
association between OSAS and hyperactivity (Blunden S. et al., 2000), masking 
EDS. 
1.2 Definition of Childhood OSAS 
Definition of childhood OSAS has not yet been standardized. Application of the 
definition in adults to children may lead to under-diagnosis (Rosen CL. et al., 1992). 
Owing to the higher respiratory rate in children, only counting apneas lasted for 10 
seconds or more may underestimate the severity of OSAS (American Thoracic 
Society, 1989). In addition, children usually have more partial upper airway 
obstruction than complete obstruction, which means definition of OSAS based only 
on the number of apneas per hour of sleep may cause under-recognition of the 
condition (Rosen CL. et al., 1992). But the definition of hypopnea in children has not 
yet been standardized, making comparison between studies very difficult. 
Regarding the normal ranges for polysomnographic parameters in children, 
Marcus CL. et al. (1992b) suggested that less than one apnea per hour of sleep 
should be considered statistically normal. The same group recently revised the 
11 
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normal value and adjusted to apnea-hypopnea index (AHI) of less than 1.5 per hour 
of sleep (Witmans MB. et al., 2003). Another study suggested that hypopneas are 
rare in normal children (Uliel S. et al., 2004). More recently, it was suggested that an 
AHI of greater than one event per hour of sleep should be considered as abnormal 
(Traeger N. et al., 2005; Uliel S. et al” 2004). However, the cutoff value of AHI 
associated with complications has not yet been determined in children. 
1.3 Prevalence of Childhood OSAS 
OSAS can affect children of all ages, from neonates to adolescents. 
Theoretically, it should be most common in preschool-aged children, as the tonsils 
and adenoids are largest relative to airway size at this stage, resulting in the 
narrowing of the upper airway (Jeans WD. et al,, 1981). Epidemiological data of 
childhood OSAS are scarce. Existing data show that the prevalence is around 2% in 
middle-school-aged children (Rosen CL. et al., 2003; Wing YK. et al., 2003) and 
13% in preschool-aged children (Castronovo V. et al., 2003). Prevalence of 
childhood OSAS was showed to be higher in blacks and in former preterm children 
(Redline S. et al., 1999; Rosen CL. et al., 2003). Symptoms of OSAS also appear to 
be increased in Hispanic children (Goodwin JL. et al” 2003). However, all these 
findings were not based on conventional polysomnography as the diagnostic method. 
11 
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1.4 Pathophysiology 
Upper airway resistance increases during sleep, even in normal humans, 
resulting in airway narrowing (Hudgel DW. et al., 1984; Wiegand L. et al., 1989). 
This is owing to the reduction in muscle tone of the pharyngeal dilator muscles 
(Tangel DJ. et al., 1991; Wiegand DA. et al., 1990a; Wiegand DA. et al., 1990b). 
During inspiration, negative pressure is generated in the upper airway. In healthy 
individuals, this negative pressure is balanced by the activity of the pharyngeal 
dilator muscles so that the upper airway does not collapse (Remmers JE. et al., 1978). 
However, when the upper airway resistance is increased due to other factors such as 
adenotonsillar hypertrophy, or when the upper airway neuromotor function is 
abnormal, the upper airway collapses at a lower threshold (Marcus CL. et al., 1994a; 
Marcus CL, 2000). 
In normal children, the adenoids and tonsils enlarge during childhood, from 
infancy until adolescence, and then shrink with time (Brodsky L, 1989; Fujioka M. et 
al., 1979; Vogler RC. et al., 2000). At the same time, the bony structure of the 
nasopharynx also grows gradually, but it grows much slower than the adenoids and 
tonsils, especially during the period between 3 and 6 years of age. Thus, the resultant 
upper airway size is narrowest during this period (Jeans WD. et al., 1981). This 
coincides with the peak prevalence of childhood OSAS. Several studies showed that 
4 
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children with OSAS have larger adenoids and tonsils when compared to age-matched 
control subjects (Arens R. et al” 2001; Brooks LJ. et al., 1998; Fembach SK. et al., 
1983). However, the relationship between the size of lymphoid tissues and the 
severity of OSAS was not shown to be linear (Brooks LJ. et al., 1998; Fernbach SK. 
et al., 1983; Laurikainen E. et al., 1987). This may be because children with OSAS 
have a more collapsible upper airway when compared to children without OSAS 
(Marcus CL. et al., 1994a). Furthermore, craniofacial abnormalities may also play a 
role in the pathogenesis of childhood OSAS, although the correlation between 
craniofacial measurements and polysomnographic parameters in children has not yet 
been well established. 
In short, the pathophysiology of childhood OSAS is likely to be a complex 
interaction between physiological factors such as ventilatory drive and 
neuromuscular function and anatomical factors such as airway morphology and 
adenotonsillar enlargement. 
11 
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1.5 Risk Factors 
The risk factors of OSAS in children are not exactly the same as those in adults. 
In adults, airway obstruction during sleep appears to be strongly correlated with male 
gender, ventilatory instability and overweight (Strohl KP. et al., 1986). A study 
estimated that 1% increase in body mass index (BMI) lead to a 3% increase in 
apnea-hypopnea index (AHI) (Peppard PE. et al., 2000a). Another study 
demonstrated that a 10% increase in BMI increases the risk of OSAS by six-fold 
(Tishler PV. et al., 2003). Besides, the effect of overweight on the severity of OSAS 
in men was showed to be greater when compared with women (Newman AB. et al” 
2005; Redline S. et al, 2003). 
Overweight possibly increases the risk of adulthood OSAS in multiple ways, 
including effects on lung mechanics and ventilation, and on airway size. Imaging 
studies showed that adults with OSAS, compared to normal controls, have increased 
parapharyngeal fat pads or visceral neck fat (Schwab RJ. et al., 2003; Shelton KE. et 
al., 1993). The fat deposition in the neck region is presumed to decrease the airway 
size, making it more collapsible. 
In contrast, the risk of childhood OSAS in different gender appears to be equal 
(Rosen CL. et al., 2003). Moreover, childhood OSAS is only weakly associated with 
overweight. In a study with a small number of subjects, upper airway narrowing is 
11 
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mainly associated with large tonsils and adenoids, but not parapharyngeal fat 
deposition (Arens R. et al., 2003). This is consistent with the observation that 
adenotonsillar hypertrophy, instead of obesity, is the most common risk factor of 
childhood OSAS (American Academy of Pediatrics, 2002). 
The association between OSAS and overweight is likely to be age-dependent. 
One study showed that overweight children aged 4 - 1 8 years are at 4.6 times higher 
risk when compared to normal weight children (Redline S. et al., 1999). In contrast, 
another study involved a cohort of children between 8 and 11 years old showed that 
overweight did not significantly increase the risk for OSAS (Rosen CL. et al., 2003). 
However, five years later, follow-up assessment of this cohort found overweight 
increased the risk of OSAS by more than nine-fold (S.R.，unpublished). This 
observation evoked a hypothesis: OSAS is weakly associated with obesity in younger 
children and strongly associated with obesity in adolescents. This hypothesis was 
supported by several pediatric studies (Anuntaseree W. et al., 2001; Sachez-
Armengol A. et al., 2001; Sogut A. et al., 2005). 
However, results from a study in Hong Kong were not consistent with the 
hypothesis. The study showed that there was a strong association between obesity 
and childhood OSAS in children aged 7 - 1 1 years. More interestingly, it also 
showed that overweight was associated with both adenoid hypertrophy and 
11 
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velopharyngeal narrowing (Wing YK. et al., 2003). This suggested that overweight 
can increase the risk of childhood OSAS via different pathways. Another study also 
demonstrated that the risk of OSAS for Asian adults could be increased by lower 
levels of BMI when compared to Europeans (Ip MS. et al., 1998). This may be due 
to the differences in body fat composition and craniofacial features between different 
ethnic groups (Ip MS. et al, 1998; Liu YH. et al., 2000). 
Indeed, genetic risk factors have been identified in the development of OSAS. 
Clearly, there is an increased risk of OSAS in a family in which a member is affected 
(Ovchinsky A. et al., 2002; Pillar G. et al., 1995; Redline S. et al., 1995). Oral 
mucosa thickness and skull base length have been identified as the ethnic risk factors 
in African Americans and in Far East Asians respectively (Ng TP. et aL, 1998). 
African American and Far East Asian populations have been shown to have 
significantly higher risk of OSAS when compared to Caucasians, even after 
adjustment was made for age, sex, and body mass index (Ng TP. et aL, 1998; 
Ovchinsky A. et al., 2002; Pillar G. et aL, 1995; Redline S. et al., 1995; Redline S. et 
al., 1997). Familial cases of OSAS can be found in all ethnic groups. However, the 
specific gene responsible for the increased risk has still not yet been located. 
Furthermore, childhood OSAS is also associated with allergic rhinitis (AR) (Ng 
DK. et al., 2006). The association may be explained by the increased nasal resistance 
11 
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or obstruction, causing increased negative pressure swings. Besides, AR may also 
cause airway inflammation and narrowing, eventually increasing the collapsibility of 
the upper airway. There is convincing evidence supporting that AR increases the risk 
of childhood OSAS. It was also showed that appropriate treatment of AR could 
prevent the occurrence of OSAS and reduce the severity of existing OSAS (Ng DK. 
et al., 2006). 
In some cases, OSAS may be simply caused by a single risk factors such as 
overweight or adenotonsillar hypertrophy. After removing the risk factor, the 
problem may be completely resolved. However, in other cases, it appears that 
childhood OSAS is more commonly the result of the interaction between several 
anatomic and physiological risk factors. Additional research is needed to investigate 
the interaction between individual risk factors, and to quantify the association 
between individual risk factors with OSAS. 
11 
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1.6 Diagnosis 
Habitual snoring is one of the most common symptoms of childhood OSAS. 
However, diagnosis based on symptoms only will not give an accurate result (Carroll 
JL. et al., 1995). Adenotonsillar hypertrophy is found to be the most common cause 
of childhood OSAS. However, the sizes of tonsils and adenoids are not associated 
with the presence or severity of OSAS (Carroll JL. et al., 1995; Li AM. et al., 2002). 
Overnight PSG is still considered as the "gold standard" for the diagnosis of the 
condition although the diagnostic cutoff has not yet been well-established (as 
previously mentioned). 
Polysomnography (PSG) in children involves the simultaneous recording of 
sleep state, respiration, ECG, muscle activity, arterial oxygen saturation, end-tidal 
CO2 level and snoring (American Thoracic Society, 1996). It is suggested that a 
parent should stay with the child throughout the night of PSG in order to minimize 
the effect of sleep laboratory environment on the child's usual sleep patterns 
(American Thoracic Society, 1996). It is also suggested that sleep tests in children 
should be observed closely by trained technologists in order to ensure that the quality 
of recording is good. 
The most controversial issue of the technical aspects of PSG in children is 
which method we should used to quantify tidal volume and flow. Thermistor, which 
10 
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measures air flow by its heat sensitive electrodes, is commonly used in PSG for 
children, but it cannot accurately quantify tidal volume. The use of nasal pressure 
recordings has been proposed to be a more sensitive tool in detecting airway 
obstruction, especially for hypopneas (Trang H. et al., 2002). However, signal may 
be easily lost when the catheter becomes detached from the nose or the subject is a 
chronic mouth breather. Respiratory inductance plethysmography which does not 
need any facial transducers may be more reliable for children and infants (Adams JA. 
et al., 1993b; Adams JA. et al., 1993a). 
Since PSG is not widely available and the test itself may disturb sleep, less 
disturbing alternatives which can be performed at home such as overnight oximetry 
(Brouillette RT. et al., 2000) and daytime nap polysomnography (Marcus CL. et al., 
1992a) are recommended. These tests have a high specificity but a low sensitivity. 
Thus, children with a negative result will still need a full PSG for confirmation 
(American Thoracic Society, 1996; Schechter MS, 2002), those with positive result 
may avoid waiting for a prolonged period before PSG is carried out (Brouillette RT. 
et al, 2000). 
11 
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1.7 Treatment 
1.7.1 Tonsillectomy and Adenoidectomy (T&A) 
There is a lot of evidence supporting that T&A is a successful treatment for 
childhood OSAS. The efficacy in either improving or completely resolving the 
abnormal respiratory pattern during sleep was high (Lipton A J. et al., 2003; Shine 
NP. et al., 2005). It was also shown to be highly effective in improving the symptom 
of restless sleep, and in enhancing growth and reducing the incidence of abnormal 
daytime behaviour (Ali NJ. et al., 1996; Stradling JR. et al., 1990; Suen JS. et aL, 
1995). However, a prospective randomized study may not be ethical nowadays to 
allow definitive conclusion on the overall efficacy of T&A in treating childhood 
OSAS to be drawn. Moreover, some studies relied only on clinical impression or 
parental reports, instead of objective pre-operative and post-operative assessment, 
making the conclusion less powerful. A prospective study showed that 45% of 
children have persistent OSAS after T&A when post-operative PSG was performed 
(Tauman R. et al., 2004). Therefore residual problem following T&A may be more 
common than we thought. 
Regarding the risk factors for residual OSAS after T&A, a study reported by 
Suen et al suggested that in a cohort including 26 children, those with an AHI > 19 
was more likely to have a postoperative AHI > 5 (Suen JS. et al., 1995). More 
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recently, another study suggested that children who are obese, belong to ethnic 
minorities and have a family history of SDB were at higher risk for persistent OSAS 
after T&A (Rosen CL. et al., 2001). 
In general, T&A itself is a low risk procedure. The mortality and morbidity 
were reported to be ranged from 1 in 4,000 to 1 in 27,000 cases (Rowe LD, 1995) 
and 5 - 10% respectively (American Academy of Pediatrics, 2002). However, for 
patients with OSAS, the morbidity of the procedure may be increased to 18 - 34% 
(American Academy of Pediatrics, 2002). Therefore, it is recommended that patients 
should stay in hospital after the procedure and monitored overnight. 
Potential complications of adenotonsillectomy include anesthesia-related 
complications (Blum RH. et al., 2004; Brown KA. et al., 2003), upper airway 
obstruction, hemorrhage, immediate postoperative problems such as pain and poor 
oral intake, pulmonary edema (Feinberg AN. et al., 1985; Randall DA. et al., 1998), 
dehydration and hypersomnolence. Death attributable to respiratory complications in 
the immediate postoperative period has been reported in patients with severe OSAS. 
Identified risk factors include age of less than 3 years (Wiatrak BJ. et al., 1991), 
severe preoperative OSAS confirmed by PSG (Mccolley SA. et al., 1992; Rosen GM. 
et al., 1994), cor pulmonale, morbid obesity (Price SD. et al., 1993), history of 
prematurity, recent respiratory infection, craniofacial anomalies and neuromuscular 
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disorders (Biavati MJ. et al., 1997; Mccolley SA. et al., 1992; Rosen GM. et al., 
1994; Rothschild MA. et al., 1994; Wiatrak BJ. et al., 1991). 
1.7.2 Continuous Positive Airway Pressure (CPAP) 
CPAP therapy is a successful, non-invasive alternative for pediatric patients who 
refuse surgical treatment, or when adenotonsillar hypertrophy is not the major cause 
of airway obstruction. It has also become the second line treatment in children and 
infants with persistent OSAS after T&A (Guilleminault C. et al., 1995; Marcus CL. 
et al., 1995; Marcus CL. et al., 2006; McNamara F. et al., 1999; Waters KA. et al., 
1995). CPAP maintains the airway open by delivering constant positive pressure 
through a nasal or face mask. The level of pressure must be titrated in sleep 
laboratory before any prescription and reevaluate periodically. CPAP has been 
successfully used in children with OSAS as young as newborn infants (Guilleminault 
C. et al., 1995; McNamara F. et al., 1999; Waters KA. et al., 1995). However, since it 
is a long-term therapy instead of a 1 -time procedure, extensive behavioral 
conditioning approaches may be required in order to achieve reasonable compliance 
in younger children (Rains JC, 1995). 
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1.7.3 Corticosteroids 
The use of corticosteroid as a potential alternative treatment of OSAS in 
children has been suggested by some investigators. The favorable change was 
presumed to be attributed to a decrease of upper airway resistance by the effect of 
corticosteroid on adenoidal hypertrophy and nasal mucosa inflammation (Demain JG. 
et al., 1995; Marcus CL, 2001). Initially, a study showed that a 5-day course of 
systemic prednisone did not show significant improvement in symptoms and 
home-polysomnographic parameters (Al-Ghamdi SA. et al., 1997). Later, a study 
performed by the same group of investigators showed that a 6-week course of 
intranasal fluticasone reduced both the respiratory disturbance index and the number 
of oxyhemoglobin desaturation per hour of sleep significantly, while the placebo 
group did not show improvement (Brouillette RT. et al., 2001). Another study 
showed that T&A may be prevented after 24-week low dose corticosteroid treatment 
(Criscuoli G. et al., 2003). More recently, (Alexopoulos EI. et al., 2004) reported that 
the beneficial effect of intranasal corticosteroids could be maintained for several 
months after discontinuation of the medication. However, the use of nasal 
corticosteroids cannot supersede T&A and CPAP because the improvement in OSAS 
is modest (Marcus CL, 2001). Further studies are needed to investigate which group 
of patients with OSAS are better candidates to be treated by this therapy. 
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1.7.4 Leukotriene Receptor Antagonist 
Children with OSA were recently found to have elevated expression of cysteinyl 
leukotriene receptors in their upper airway tissues (Goldbart AD. et al., 2004). 
Besides, leukotrienes were identified as possible inflammatory mediators responsible 
for upper airway inflammation (Goldbart AD. et al., 2006). These findings prompted 
researchers to try to use leukotriene receptor antagonist as the new treatment strategy 
for childhood OSAS. Preliminary results in an open-label study suggested that daily 
montelukast therapy can improve most polysomnographic parameters significantly in 
children with mild OSAS (Goldbart AD. et al., 2005). In addition, a combination of 
intranasal steroids and oral montelukast was shown to be effective in treating mild 
residual OSAS following tonsillectomy and adenoidectomy in children (Kheirandish 
L. et al‘, 2006). 
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1.8 Complications of Childhood OSAS 
1.8.1 Growth Failure 
It is observed that the incidence of growth failure was much higher in several 
studies involving children presenting for T&A or having OSAS assessed (Freezer NJ. 
et al., 1995; Selimoglu E. et al., 2003; Williams EF. et al., 1991). This supports the 
hypothesis that SDB increases the risk of growth failure in children. There is also 
overwhelming evidence suggesting that after T&A, the gains in weight and in height 
are greater than expected (Ahlqvistrastad J. et al., 1992; Everett AD. et al., 1987; 
Freezer NJ. et al., 1995; Marcus CL. et al., 1994b; Nieminen P. et al., 2002; 
Schiffmann R. et al., 1985; Selimoglu E. et al., 2003; van Staaij BK. et aL, 2004; 
Williams EF. et aL, 1991; Yilmaz MD. et al., 2002). This suggests a causal 
relationship between childhood OSAS and growth failure. 
The causal relationship between OSAS and growth failure may be explained by 
the increased sleep energy expenditure in patients with OSAS. The association 
between OSAS and increased sleep energy expenditure appears to be true in adults 
(Stenlof K. et al., 1996). In children SDB was shown to lead to an increased caloric 
expenditure because of the forceful breathing during sleep (Marcus CL. et aL, 1994b). 
Another study showed that children with OSAS had a non-significantly higher sleep 
energy expenditure when compared to controls (Li AM. et al” 2003). 
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Moreover, since childhood OSAS can cause neurological dysfunction, the 
feeding ability of children with OSAS may be impaired (Manikam R. et al., 2000). In 
addition, adenotonsillar hypertrophy-induced dysphagia may also reduce appetite 
(Dusick A, 2003; Manikam R. et al., 2000) causing inadequate intake and hence 
growth failure as a sequelae. 
It has also been hypothesized that children with SDB have impaired growth 
hormone secretion, which may be due to the interruptions in slow-wave sleep, in 
which a large amount of growth hormone is secreted (Phillip M. et al., 1998). 
Several studies reported that after T&A in children with OSAS, levels of circulating 
insulin-like growth factor (IGF-1) and/or insulin-like growth factor binding protein 3 
(IGFBP-3) would increase (Nieminen P. et al., 2002; Yilmaz MD. et al., 2002). 
Since both IGF-1 and IGFBP-3 have been shown to correlated significantly with 
nocturnal GH secretion (Blum WF. et al., 1993), increases in these two markers 
imply an increase in nocturnal GH secretion. In addition, the IGF-1 level was also 
shown to be correlated with the level of leptin (Kratzsch J. et al., 2002; Palacio AC. 
et al., 2002), which is a hormone related to both fatness and bone metabolism during 
human development (Whipple T. et al., 2002). 
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1.8.2 Neurocognitive Abnormalities 
Childhood OSAS, even mild cases, appears to be associated with behavioural 
abnormalities, learning difficulties, poor attention, hyperactivity and a below-average 
intelligent quotient (Blunden S. et al., 2000; Chervin RD. et al., 1997; Gozal D, 1998; 
Weissbluth M. et al,, 1983; Whipple T. et al., 2002). The underlying mechanism 
linking childhood OSAS and neurocognitive dysfunction is unclear. A study showed 
that rats exposed to intermittent hypoxia during sleep is associated with extensive 
spatial learning deficits and increased neuronal apoptosis within susceptible brain 
regions including the hippocampus and the cortex (Gozal D. et al., 2001). Later, the 
same group of investigators suggested that the hypoxia-induced spatial deficits in rats 
may be explained by the upregulation and activation of cyclooxygenase-2, which is 
an enzyme upregulated in several neurologic diseases including stroke (del Zoppo G. 
et aL, 2000; Gozal D. et al., 2001), Alzheimer's disease (Mcgeer PL. et al., 2001; 
Xiang ZM. et al., 2002) and seizures (Mccown TJ. et aL, 1997). Further research will 
be needed to investigate whether the same mechanism applies to humans. Another 
study suggested that micro-arousals or subcortical arousals might also play a role in 
causing neurocognitive dysfunction in childhood OSAS (Katz ES. et aL, 2003). 
Neuropsychological dysfunction associated with mild sleep apnea might be 
reversible in children. Gozal demonstrated that school performance of children with 
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SDB was significantly improved after treatment with tonsillectomy while no such 
improvement was observed in the non-treatment group (Gozal D, 1998). In addition, 
a controlled trial involving children aged 5-9 years with mild OSAS showed that 
cognitive performance, including executive function, learning, and visual and verbal 
short-term memory, could be normalized after treatment with T&A (Friedman BC. et 
al., 2003). However, a recent study involving preschool children from low-income 
families showed that despite resolution of abnormal respiratory pattern following 
T&A, verbal fluency scores remained abnormal (Montgomery-Downs HE. et al., 
2005). This suggested that some neuropsychological deficits in preschool children 
with OSAS might be irreversible. 
1.8.3 Cardiovascular Abnormalities 
Childhood OSAS was reported to cause blood pressure dysregulation, 
sympathetic activation, cor pulmonale and left ventricular hypertrophy (Ng DK. et 
al., 2005). The relationship between childhood OSAS and cardiovascular diseases 
will be further discussed in later chapters. 
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CHAPTER 2 
Cardiovascular Complication of 
OSAS in Adults 
(Literature Review) 
2.1 Acute Effects of OSAS on Cardiovascular System 
OSAS is a sleep-related breathing disorder characterized by repetitive upper 
airway narrowing or occlusion resulting in a variety of acute responses such as 
hypoxemia and reoxygenation, negative intrathoracic pressure and arousals. These 
acute responses affect the respiratory, cardiovascular and central nervous systems in 
a complex way. 
Hypoxemia may stimulate peripheral arterial chemoreceptors in patients with 
sleep apnea (Narkiewicz K. et al., 1999). This increased chemoreflex sensitivity may 
be the primary mediator of enhanced sympathetic tone in patients suffering from 
OSAS. The sympathetic activation then leads to acute increase in arterial blood 
pressure (Narkiewicz K. et al1999; Somers VK. et al1995). Lung inflation 
mediated by vagal nerves has been shown to be incomplete during apneas and 
hypopneas (Smith ML. et al., 1996; Somers VK. et al., 1993). Moreover, several 
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disease states such as hypertension and heart failure may result in impaired 
baroreflex function (Hedner JA. et al., 1992), which under normal conditions buffers 
the sympathetic responses to chemoreflex activation (Somers VK. et al1991). 
Besides, intermittent hypoxia and reoxygenation can lead to the formation of reactive 
oxygen species (ROS) and increased oxidative stress (Prabhakar NR, 2001). ROS are 
highly reactive molecules that react with nucleic acids, lipids and proteins and hence 
hinder cellular metabolism resulting in cell injury (Droge W, 2002). Increased ROS 
production can lead to endothelial dysfunction and eventually result in 
atherosclerosis (Lavie L, 2003). 
The increased inspiratory efforts against the obstructed upper airway causes 
marked negative intrathoracic pressure that results in acute increase in pulmonary 
arterial pressure, blood flow and cardiac afterload (Bonsignore MR. et al., 1994). 
Resulting increased venous return can lead to leftward shift of the interventricular 
septal wall (Shiomi T. et al., 1991). The negative intrathoracic pressure may also 
increase the transmyocardial pressure gradient, impairing the diastolic function of 
LV. In the long run, reduced diastolic function would predispose one to congestive 
heart failure. 
Arousals during sleep are more frequent in OSAS patients as it can help to 
terminate apneas and hypopneas and resume breathing (Gleeson K. et al., 1990). In a 
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human study, arousals induced by acoustic stimuli have been shown to result in 
sudden surge in sympathetic tone, heart rate and blood pressure (Blasi A. et al., 2003; 
Morgan BJ. et al., 1996). This suggests an independent effect of arousals on 
cardiovascular risks. 
2.2 Chronic Effects of OSAS on Cardiovascular System 
Sympathetic activation appears to be carried over into daytime in some patients 
with OSAS, even under conditions of normoxia. Abnormal variability in both 
daytime heart rate and daytime blood pressure have been documented in patients 
with OSAS, suggesting an increased cardiovascular risk (Narkiewicz K. et aL, 
1998b). 
Moreover, increased sympathetic tone, repetitive hypoxemia and sleep 
deprivation (Gottlieb DJ. et al., 2005) induced by OSAS may impair glucose 
tolerance. The independent association between glucose intolerance and OSAS has 
been reported in both clinical and population-based studies (Ip MS. et aL, 2002; 
Punjabi NM. et al., 2002). A study has shown an improvement in insulin sensitivity 
in subjects with an AHI greater than 20 after CPAP therapy for 2 nights, and the 
improvement maintained in the following 3 months (Harsch lA. et aL, 2004). 
OSAS can result in inflammation that can also lead to cardiovascular disease 
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(Hansson GK, 2005). C-reactive protein (CRP) is a sensitive marker of inflammation 
that has been shown to be a strong predictor of cardiovascular events (Ridker PM. et 
al., 2002). CRP has been shown to be elevated in OSAS patients in some 
(Shamsuzzaman ASM. et al., 2002), but not all (Guilleminault C. et al., 2004a), 
studies. CRP levels have also been shown to positively correlate with the severity of 
OSAS, independent of the effect of body mass index (Teramoto S. et al., 2003). 
CPAP therapy has been reported to reduce CRP levels (Yokoe T. et al” 2003). 
2.3 Hypertension 
There is strong evidence that OSAS is an independent risk factor for systemic 
hypertension (Dart RA. et al., 2003; Lattimore JDL. et al., 2003; Robinson GV. et al., 
2004). Careful case-control studies have confirmed the association of sleep apnea 
and increased blood pressure independent of confounders such as obesity (Davies 
CW. et al., 2000). 
Several population-based studies have yielded a relationship between OSAS and 
hypertension. The Sleep Heart Health Study, which included more than 6,000 
individuals, showed a definite independent association between OSAS and 
hypertension, and the prevalence of hypertension was increased with the severity of 
OSAS (Nieto FJ. et al., 2000). Similarly, the Wisconsin Cohort Study of 1,069 
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patients revealed the apnea-hypopnea index as being an independent predictor of 
daytime hypertension (Young T. et al1997). The same group of investigators 
performed a follow-up study in a subgroup of the previous cohort (893 patients 
included) (Peppard PE. et al., 2000b). The study demonstrated a dose-response 
relationship of sleep-disordered breathing at baseline and the incidence of 
hypertension in a four-year observation. The analysis was carried out after 
adjustment for baseline hypertension status, body-mass index, neck and waist 
circumference, age, sex, and weekly use of alcohol and cigarettes. The odds ratios for 
the incidence of hypertension were 1.42 (95% CI: 1.13 - 1.78) with an 
apnea-hypopnea index of 0.1 to 4.9 events per hour at baseline as compared with 
none, 2.03 (95% CI: 1.29 - 3.17) with an apnea-hypopnea index of 5.0 to 14.9 events 
per hour, and 2.89 (95% CI: 1.46 — 5.64) with an apnea-hypopnea index of 15.0 or 
more events per hour of sleep. Thus, obstructive sleep apnea increases the risk of 
incidence of hypertension in the general population, indicating a genuine and robust 
relationship between OSAS and hypertension. 
OSAS has been found to be more common in patients with treatment-refractory 
hypertension (Logan AG. et al., 2001); conversely, controlling hypertension by 
conventional therapeutic means has been found to be more difficult in patients with 
OSAS than in hypertensive individuals without OSAS (Hirshkowitz M. et al., 1989). 
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Recently, the association between sleep apnea and arterial hypertension has 
been shown to be attenuated by aging (Haas DC. et al., 2005). The analysis of the 
Sleep Heart Health Study has shown an independent association of OSAS and 
hypertension but only in the group of middle-aged subjects. Such correlation was not 
noticed within the elderly group (aged over 60). 
Interestingly, the effects of OSAS on systolic BP and diastolic BP appears to be 
different. The isolated increase in diastolic blood pressure might be the earliest 
hypertensive change associated with OSAS (Baguet JP. et al., 2005; Sharabi Y. et al., 
2003), whereas isolated systolic hypertension was uncommon in subjects with SDB 
(Grote L. et al•’ 2001). It was also demonstrated that nocturnal hypertension 
appeared to be a common and an underestimated condition in newly diagnosed 
OSAS patients (Baguet JP. et al., 2005). This emphasizes the importance of 
ambulatory blood pressure measurement in diagnosing hypertension in patients with 
OSAS. 
The mechanism linking OSAS and hypertension is not well understood. 
Sympathetic over-activity was suggested to be one of the factors that contribute to 
the etiology of hypertension in patients with OSAS (Fletcher EC, 2003). Intermittent 
hypoxia during sleep was shown to be one of the mechanisms linking OSAS and 
systemic hypertension in studies utilizing dog (Brooks D. et al., 1997) and rat 
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(Fletcher EC, 2001) model. A study in adult human also suggested that nocturnal 
hypoxemia was associated with sympathetic activation that spills over at least into 
the first hour or so after waking up from sleep (Peled N. et al., 1998). However, in a 
randomized controlled study, blood pressure decreased in the group of OSAS 
patients receiving effective CPAP, but no reduction in blood pressure was observed 
in the group receiving sham-CPAP with supplemental nocturnal oxygen for 2 weeks 
(Norman D. et al., 2006). Therefore, the role of intermittent hypoxia on blood 
pressure control in humans is still unclear. Other potential mechanisms include 
hyperleptinemia, insulin resistance, endothelial cell dysfunction and impaired 
baroreflex function (Wolk R. et al., 2003). 
Prospective randomized trials have showed that continuous positive airway 
pressure (CPAP) treatment can decrease both daytime and nighttime blood pressure 
(Faccenda JF. et al., 2001; Pepperell JC. et al., 2002; Wilcox I. et al, 1993). The 
treatment effects of CPAP on blood pressure control are especially obvious in 
patients with severe OSAS (Becker HF. et al., 2003; Dhillon S. et al., 2005; Logan 
AG. et al., 2003). However, Becker et al. have demonstrated a lack of blood pressure 
decrease despite a 50% reduction in the apnea-hypopnea index after CPAP (Becker 
HF. et al., 2003). This suggested that the reduction in blood pressure might be 
limited to the group of patients who were effectively treated. More interestingly, 
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several randomized controlled trials suggested that CPAP treatment was not effective 
in reducing the blood pressure of normotensive subjects with severe OSAS but 
without significant daytime sleepiness (Barbe F. et al., 2001; Robinson GV. et al., 
2006; Robinson GV. et al., 2004) or frequent oxyhemoglobin desaturations 
(Robinson GV. et al., 2004). Therefore, the exact therapeutic role of CPAP therapy 
in OSAS-related hypertension, and hence the mechanism linking between OSAS and 
hypertension, requires further investigation. 
2.4 Heart Failure 
Epidemiologic studies have suggested a strong association between heart failure 
and OSAS (Javaheri S. et al., 1998; Sin DD. et al., 1999). However, the subjects 
included in these studies were referred to sleep labs, resulting in a biased sample. A 
study demonstrated a shift in the predominance of the form of sleep-disordered 
breathing in patients with heart failure from obstructive to central apneas over the 
course of a night, suggesting the decreasing cardiac function during sleep of a patient 
with OSAS (Tkacova R. et al., 2001). 
In a study using canine model, experimentally induced upper airway occlusion 
has been shown to cause acute elevation of left ventricular transmural pressure and 
also an abrupt decrease in left ventricular stroke volume (Brooks D. et al., 1997). 
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Further study by inducing chronic intermittent upper airway occlusion for 3 months 
demonstrated an impairment of left ventricular systolic function. In humans, 
inspiring against a closed glottis result in a reduction in cardiac output in patients 
with heart failure, compared to those without heart failure. This suggests that patients 
with heart failure together with OSAS may further impair the cardiac function during 
sleep (Bradley TD. et al., 2001). 
There is overwhelming observational data suggesting that left ventricular 
systolic dysfunction is associated with OSAS in adults (Laaban JP. et aL, 2002). 
However, randomized controlled studies in this issue are scarce. A small but 
well-controlled, randomized study included twelve subjects in each arm has shown 
significant improvement in left ventricular ejection fraction (LVEF) and reduced 
systolic daytime systolic blood pressure after CPAP treatment for OSAS in patients 
with heart failure, compared to those received only medical therapy (Kaneko Y. et al., 
2003a). Another randomized study with a larger sample size found a significant 
improvement in LVEF but not daytime blood pressure after 3 months of CPAP 
treatment. But the subjective daytime sleepiness in this group was also mild 
(Mansfield DR. et aL, 2004). It may be noteworthy that despite both the treatment 
and control groups in these two studies had severe OSAS and LVEF of less than 40%, 
they did not have significant subjective daytime sleepiness at baseline. Further 
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research investigating the treatment effect of CPAP therapy on heart failure in the 
presence of daytime sleepiness is required. 
Diastolic dysfunction has been shown to be associated with OSAS in some 
(Chan J. et al., 1997; Fung JW. et al., 2002), but not all (Niroumand M. et aL, 2001) 
studies. A possible explanation for these inconsistent results is the uncontrolled 
designs, making them vulnerable to confounding factors such as preexisting 
hypertension, effect of cardiac medications and the chronicity of OSAS. A 
randomized controlled trial has shown a higher prevalence of abnormal left 
ventricular filling pattern in patients with newly diagnosed OSAS, when compared to 
the healthy control group. The impairment was significantly improved after 12 weeks 
of effective CPAP therapy (Arias MA. et al” 2005). 
2.5 Pulmonary Hypertension 
The role of OSAS in pulmonary hypertension is controversial. Early findings 
implicated that OSAS might not cause daytime pulmonary hypertension in the 
absence of clinical lung disease. Several earlier studies demonstrated an association 
between OSAS and increased pulmonary pressure in a group of patients having both 
OSAS and chronic obstructive pulmonary disease (Chaouat A. et al., 1996; 
Weitzenblum E. et al., 1988). More recent data have shown such an association in 
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the absence of clinical lung or left heart diseases (Sajkov D. et al., 1994). However, 
the elevations of pulmonary artery pressure were just modest. Other studies have 
shown that CPAP therapy could decrease pulmonary pressures in OSAS patients 
with either high or normal pulmonary pressures (Alchanatis M. et al., 2001; Sajkov 
D. et al, 2002). 
Cross-sectional data have shown an increase in right ventricular wall thickness 
in obese patients with severe OSAS (Guidry UC. et al., 2001). In addition, a recent 
study has shown right ventricular dilatation and dysfunction in patients with severe 
OSAS (Shivalkar B. et al., 2006). The right ventricular function was also shown to 
be inversely correlated with the severity of OSAS (Dursunoglu N. et al., 2005), and 
the effect appeared to be reversed by CPAP therapy (Dursunoglu N. et al., 2006; 
Shivalkar B. et al., 2006). These changes in the right ventricular structure and 
function may be owing to the repetitive elevations of pulmonary artery pressure and 
pulmonary vascular resistance resulting from OSAS. 
2.6 Arrhythmias 
Recent cross-sectional data from the Sleep Heart Health Study showed that 
subjects with AHI greater than 30, when compared to those with AHI less than 5, had 
a higher prevalence of atrial fibrillation, nonsustained ventricular tachycardia and 
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complex ventricular ectopy, after adjusting for age, sex, body mass index and 
presence of coronary heart disease (Mehra R. et al., 2006). However, owing to the 
cross-sectional design, the causative role of OSAS on arrhythmias cannot be 
concluded by this kind of study. 
Bradycardia has been shown to be associated with OSAS in adults. It is believed 
to be resulted from increased vagal output to the heart during apnea. Although the 
association was found only in a small group of patients with OSAS, these findings 
were obtained in the absence of any heart disease and were reversed by effective 
CPAP therapy (Becker H. et al., 1995; Grimm W. et al., 2000; Guilleminault C. et aL, 
1983). However, the Sleep Heart Health Study did not find significant difference in 
the prevalence of conduction delays between subjects with severe OSAS and those 
without significant OSAS (Mehra R. et al., 2006). 
A study of clinic population using a validated questionnaire to diagnose OSAS 
showed a higher prevalence of atrial fibrillation in the positive group when compared 
to the negative group (Garni AS. et al., 2004). Case reports have shown the shift from 
sinus rhythm to atrial fibrillation during sleep in patients with untreated OSAS 
(Schulz R. et al., 2005), and the abolishment of atrial fibrillation after CPAP therapy 
(Bridgman JC. et aL, 2006). More interestingly, patients with untreated OSAS were 
found to have about 2 times higher arrhythmia recurrence rate, when compared to 
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those treated with CPAP, within a year of successful electrical cardioversion 
(Kanagala R. et al., 2003). All these data have suggested an association between 
OSAS and atrial fibrillation. 
There is data demonstrating an improvement in central as well as obstructive 
apneas after overdrive atrial pacing in bradycardiac patients (Garrigue S. et al., 2002). 
However, this finding has not been confirmed by subsequent clinical trials (Pepin JL. 
et al., 2005; Simantirakis EN. et al.’ 2005), except one that demonstrated a modest 
reduction in the number of obstructive hypopneas per hour of sleep (Luthje L. et al., 
2005). In summary, overdrive pacing does not appear to have a treatment effect on 
OSAS in patients with arrhythmias. 
2.7 Cardiac Ischaemia and Vascular Disease 
Several studies have reported a high prevalence of OSAS in patients with 
atherosclerotic heart disease (Andreas S. et al., 1996; Mooe T. et al., 1996). In 
addition, some data supported that OSAS in patients with coronary artery disease is 
associated with worse long-term prognosis when compared to those without OSAS 
(Mooe T. et al., 2001; Peker Y. et cd., 2000). ST-segment depression during sleep has 
also been reported in OSAS patients and the duration of the depression was 
significantly reduced by CPAP therapy (Hanly P. et al., 1993). 
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The vascular system or endothelium has been reported to be possibly impaired 
in patients with OSAS. Large population studies suggested that endothelial 
dysfunction may be an important marker of cardiovascular risk (Lerman A. et aL, 
2005). Vasoactive substance representing endothelial function of small vessel such as 
acetylcholine has been reported to be reduced in patients with OSAS in some 
(Carlson JT. et al., 1996; Kato M. et al., 2000), but not all studies (Kraiczi H. et aL, 
2000). Another study found significant correlations between the severity of OSAS 
and the reduced level of a potent vasodilator, nitric oxide, and the nitric oxide level 
increased after CPAP therapy (Ip MS. et aL, 2000). The level of serum endothelin, a 
potent vasoconstrictor, appeared to be elevated in patients with OSAS when 
compared to controls (Phillips BG. et al., 1999). Furthermore, the 
hypoxemia-reoxygenation phenomenon in patients with repetitive apneic episodes 
during sleep may act as an oxidative stress on the blood vessels, resulting in free 
radical-mediated damage to the endothelium (Prabhakar NR, 2002), thus increasing 
the risk for atherosclerosis. 
2.8 Stroke 
Several studies have shown an association between stroke and sleep-disordered 
breathing (Bassetti C. et al., 1999; Dyken ME. et al., 1996; Mohsenin V. et al., 1995). 
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But these reports were cross-sectional so that the causative role of OSAS on the 
incidence of stroke cannot be confirmed. More recently, a large prospective study 
showed that self-reported snoring was associated with a modest but significant 
increase in the risk for stroke in women, independent of the effect of age, smoking, 
body mass index and other cardiovascular risk factors but not hypertension (Hu FB. 
et al., 2000). In the Caerphilly Cohort, a higher risk for the incidence of stroke was 
found in males reporting more than one of the following symptoms: snoring, 
witnessed apneas, daytime sleepiness, insomnia, and restless legs (Elwood P. et al,, 
2006). Another longitudinal study showed that OSAS significantly increased the risk 
of stroke independent of other risk factors including hypertension (Yaggi HK. et al., 
2005). 
OSAS has been shown to worsen prognosis after stroke. A study reported a 
higher mortality rate after a first episode of stroke in patients with an AHI greater 
than 30 (Parra O. et al., 2004). Another study showed that CPAP treatment had a 
protective effect against new vascular events after ischemic stroke (Martinez-Garcia 
AA. et al., 2005). Patients with stroke together with OSAS appeared to have more 
severe functional impairment and longer hospitalization during rehabilitation 
compared with those without OSAS (Kaneko Y. et aL, 2003b). 
In addition to effects on atherosclerosis and endothelial function, OSAS has 
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been shown to enhance platelet aggregation and activation (Bokinsky G. et al” 1995; 
Eisensehr I. et al., 1998), elevate fibrinogen levels (Wessendorf TE. et al., 2000) and 
reduce fibrinolytic activity (Rangemark C. et al” 1995), resulting in the promotion of 
thrombosis. Furthermore, a few studies suggested that there was an association 
between apenic events and reduced cerebral blood flow (Balfors EM. et al., 1994; 
Netzer N. et al., 1998), which may result in cerebral hypoxia (Hayakawa T. et al., 
1996). More importantly, some of these findings appeared to be reversed by CPAP 
treatment (Chin K. et al., 1996; Diomedi M. et al., 1998). However, the effect of 
CPAP treatment on the natural history of stroke in patients with both OSAS and 
stroke need to be further investigated. 
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CHAPTER 3 
Cardiovascular Complication of 
Childhood OSAS 
(Literature Review) 
3.1 Blood Pressure 
Hypertension has long been recognized and proven to be one of the 
complications in adults suffering from OSAS. However, such strong correlation has 
not been established in the paediatric population. The findings from published 
paediatric studies have been inconsistent. Marcus CL. et al. (1998) found that 
children with OSAS had significantly higher diastolic blood pressure (DBP) during 
both wakefulness and sleep when compared to patients with primary snoring. In 
addition, they also found that age, body mass index and number of apneic episodes 
per hour of sleep were independent predictors of indexed DBP. Similarly, Kohyama 
J. et al. (2003) showed that children with OSAS had higher DBP and furthermore the 
DBP was significantly correlated with the apnea-hypopnea index (AHI). In the 
Tucson Children's Assessment of Sleep Apnea study (TuCASA), the authors found 
that obesity, sleep efficiency and respiratory disturbance index (RDI) were associated 
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with an increase in blood pressure in preadolescent children (Enright PL. et al., 
2003). 
Guilleminault C. et al. (2004b) studied blood pressure in 78 prepubertal children 
with sleep disordered breathing (SDB). One child with OSAS was hypertensive (BP 
> 140/90) while seven others had low blood pressure (BP < 80/60). For the rest of 
the group, the BP was within normal range but they had significantly higher systolic 
and diastolic BP than normal subjects. The mechanism for the decrease in BP in 
childhood OSAS was unclear. A possible explanation is the dominance of vagal 
discharge as a result of increased work of breathing without hypoxaemia. 
Kwok KL. et al (2003) and Kaditis AG. et al (2005) investigated the 
relationship between habitual snoring and blood pressure elevation. The former 
group showed that children with AHI less than or equal to 1 but with habitual snoring 
had a higher daytime systolic blood pressure (SBP) and DBP as compared to age, sex 
and body size matched controls. Age, body mass index and primary snoring status 
were independent predictors of systemic BP. The latter group reported that in a 
population-based cohort including 50 parental reported habitual snorers and 760 
non-habitual snorers, no significant differences in the morning SBP or DBP values 
were documented between the two groups. The group found that body mass index 
and gender, but not habitual snoring, were significant predictors of blood pressure 
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values. All of the above studies did not utilize 24 h ambulatory BP monitoring 
(ABPM) as a method of BP measurement. 24 h ABPM has been shown to be better 
associated with end-organ damage. Amin RS. et al. (2004) reported a 24-h ABPM in 
children with different levels of AHI. They found that those with AHI greater than 5 
had significantly lower DBP during wakefulness, whereas no significant difference 
was found in sleep blood pressure and wake SBP. They also found that those with 
AHI greater than 5 had significantly more BP variability, defined as average standard 
deviation of wake and sleep blood pressure and less nocturnal BP dipping. More 
recently, Leung LCK. et al. (2006) compare the 24-h ABPM between children with 
AHI greater than 5 and those with AHI less than 5. They concluded that children 
with higher AHI had a higher wake SBP, sleep SBP and sleep DBP. In addition, they 
found that there was an association between the increased episodes of desaturation 
during sleep and the elevation of sleep DBP. Furthermore, among the subgroup of 
obese children in their cohort, those with AHI great than 5 had a higher incidence of 
hypertension than the lower AHI group. 
All in all, there is accumulating evidence that blood pressure dysregulation is 
also present in children with OSAS. The dysregulation results in either an increase or 
a decrease in BP. In a recent meta-analysis (Zintzaras E. et al., 2007) including the 
above studies except for those from Kwok et al. and Leung et al., the results showed 
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that the existing evidence was not strong enough to show elevated BP, especially 
SBP, in children with respiratory disturbance during sleep. The studies included in 
the meta-analysis were heterogeneous in terms of methods and subjects' inclusion 
criteria. The potential relationship between BP and childhood OSAS has to be further 
investigated by large, rigorously controlled and population-based studies. 
3.2 Ventricular Structure and Function 
Early studies demonstrated the relationship between cor pulmonale and OSAS 
in infants and children. Brouillette RT. et al. (1982) showed that more than half of the 
OSAS children included in their study presented with cor pulmonale which improved 
after treatment for OSAS. Another study assessed both the left and right ventricular 
function by radionuclide technique. They concluded that right ventricular 
dysfunction may present in children with OSAS secondary to adenotonsillar 
hypertrophy, prior to clinically evident cor pulmonale, and the impairment could be 
reversed by surgical treatment of OSAS (Tal A. et al” 1988). 
Most of the early studies reported dysfunction or remodeling in the right side. 
More recently, childhood OSAS was shown to affect the left ventricle too. Amin RS. 
et al. (2002) found that children with OSAS had greater left ventricular mass index 
and relative wall thickness when compared to primary snorers. In addition, they 
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demonstrated that children with AHI great than 10 had higher prevalence of RV 
dimension and left ventricular mass index above the percentile. The same group 
later showed that there was a dose-dependent decrease in left ventricular diastolic 
function with increased severity of obstructive sleep apnea in children (Amin RS. et 
al., 2005). Another study showed that children with mild OSAS may have some 
degree of left ventricular diastolic dysfunction. It also showed a relationship between 
posterior wall thickness and respiratory disturbance index (Sanchez-Armengol A. et 
al., 2003). 
Furthermore, a number of studies reported that children with adenotonsillar 
hypertrophy had a higher mean pulmonary arterial pressure, and the abnormal 
finding returned to normal in the postoperative period (Gorur K. et al., 2001; Yilmaz 
MD. et aL, 2005). Adenotonsillar hypertrophy was also shown to be associated with 
right and/or left ventricular enlargement and decreased left ventricular compliance 
(Gorur K. et aL, 2001). A negative correlation between right ventricular diastolic 
function and the adenoid size was also proposed (Tezer MS. et al., 2005). On the 
contrary, one study showed that there was no significant difference in right 
ventricular function between children with and without adenotonsillar hypertrophy 
(Pac A. et al, 2005). 
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3.3 Arterial Distensibility 
The significance of arterial distensibility is in its direct relation to the 
impedance of blood vessels, which is regarded as an index of pulsatile afterload 
presented to the left ventricle (Nichols WW. et al., 1990). Arterial distensibility can 
be estimated in vivo by measuring the pulse wave velocity, which is inversely related 
to the square root of arterial distensibility (Greenwald SE. et al., 1997). A study 
showed that children with primary snoring had a higher pulse wave velocity than 
children who do not snore, indicating decreased arterial distensibility in primary 
snorer (Kwok KL. et al., 2003). Decreased arterial distensibility causes an increase in 
cardiac afterload, which in the long run would damage one's cardiovascular health. 
3.4 Heart Rate Variability 
In adult studies, patients with OSAS tended to have faster heart rate and lower 
heart rate variability. This might be explained by the increase in sympathetic 
activation leading to vasoconstriction and increase in blood pressure (Narkiewicz K. 
et al., 1998a; Pac A. et al., 2005; Somers VK. et al., 1995). Sympathetic and vagal 
activity can be estimated by measuring the heart rate variability (Pagani M. et al., 
1986). A few studies tried to investigate the relationship between childhood OSAS 
and heart rate variability. One study compared the heart rate variability between 
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children with OSAS and controls. It showed that children with OSAS had increased 
low frequency recordings, which is believed to be responsible for sympathetic 
activation, when compared to controls during REM sleep (Baharav A. et al., 1999). 
However, another study showed that children with severe hypoxemia during sleep 
did not have significant changes in their heart rate (D'Andrea LA. et al., 1993). These 
studies were limited by their small sample size. 
In summary, although there is increasing evidence suggesting that childhood 
OSAS is associated with cardiovascular abnormalities, a definite conclusion of how 
and why they are related to each other still cannot be drawn, owing to the limited 
number of studies and the limited sample sizes, and also the diverse methods used by 
different studies. Further well-controlled and longitudinal studies are required to 
investigate the causal relationship between childhood OSAS and cardiovascular 
diseases. 
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CHAPTER 4 
Ambulatory Blood Pressure 
in Children with OSAS 
(A Community Based Study) 
4.1 Introduction 
Childhood obstructive sleep apnea syndrome (OSAS) is defined as snoring 
associated with significant night-time physiologic derangement, sleep disturbances 
and excessive daytime sleepiness (American Academy of Pediatrics, 2002). It is 
increasingly being recognised and its prevalence among the paediatric population 
may be as high as 10.3% (Redline S. et al., 1999). In adults, OSAS is an independent 
risk factor for hypertension and is involved in the initiation and progression of other 
cardiovascular diseases (Nieto FJ. et aL, 2000; Peppard PE. et al., 2000b; Shahar E. 
et aL, 2001). However, similar data is scarce for the paediatric population and the 
few published studies have reported conflicting results (Amin RS. et al,, 2004; 
Enright PL. et al., 2003; Guilleminault C. et al., 2004b; Kohyama J. et al., 2003; 
Leung LCK. et al” 2006; Marcus CL. et al., 1998). Marcus CL. et al. (1998) 
suggested that children with OSAS had higher diastolic blood pressure (DBP) during 
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both wakefulness and sleep when compared to primary snorers, whereas Amin RS. et 
al. (2004) found lower DBP among OSAS children during wakefulness. 
Guilleminault C. et al. (2004b) demonstrated that a subgroup of children with OSAS 
were hypotensive rather than hypertensive. Kohyama J. et al. (2003) documented a 
positive correlation between both systolic and diastolic blood pressure during sleep 
with severity of OSAS, and similarly Enright PL. et al. (2003) found respiratory 
disturbance index to be significantly associated with systolic and diastolic blood 
pressure. A recent paper however failed to confirm such positive association (Leung 
LCK. et al., 2006). These inconsistent findings in blood pressure measurements in 
children with OSAS may be related to the small sample size involved and the lack of 
normal healthy subjects for comparison. In some of the reported paediatric series, 
causal blood pressure measurements were used. Ambulatory blood pressure (ABP) 
measurement is nowadays considered to be a better diagnostic tool as it gives more 
reliable and reproducible results (Khattar RS. et al., 1998; Verdecchia P. et al., 
1994). 
Obesity is becoming an important factor in the study of OSAS. Obesity 
increases the risk for both cardiovascular disease for which hypertension is the 
preceding step, and OSAS. Failing to control for obesity will make assessment of the 
independent role of OSAS on blood pressure difficult. In this study, we aimed to 
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compare ambulatory blood pressure parameters of children suffering from mild and 
moderate-to-severe OSAS with normal healthy controls, and to investigate the 
correlation between severity of OSAS and blood pressure measures or hypertension, 
after adjusting for obesity. 
4.2 Methods 
4.2.1 Subjects and Study Design 
Subjects for this study were drawn from our on-going childhood OSAS 
epidemiologic study, which involved children aged between 6 and 13 years recruited 
from thirteen randomly chosen schools. Parents of these school children were asked 
to complete a validated OSAS screening questionnaire (Li AM. et al., 2006) that 
stratified children into high or low risk for OSAS. Children were excluded from the 
study if they had an intercurrent upper respiratory tract infection within 4 weeks of 
PSG, suffered from neuromuscular disorder such as Duchenne muscular dystrophy, 
craniofacial anomalies, syndromic disorder for example Down syndrome, or if they 
had previously undergone upper airway surgery. Anthropometric parameters 
including weight, height, waist and hip circumferences were measured on the day of 
PSG. Waist circumference was measured midway between the lower rib margin and 
iliac crest. Hip circumference was measured at the level of the widest circumference 
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over the greater trochanters. Body mass index (BMI) was translated to BMI z score 
according to the normal reference values of Hong Kong Chinese children (Leung SS. 
et al” 1998). Children were defined as overweight or obese if their BMI z score was 
greater than 1.04 or 1.65, corresponding to the 85出 or percentile (relative to age 
and gender) respectively. This project included the first 466 consecutive children 
who underwent PSG and consented to ambulatory blood pressure recording. 
Subjects were classified into three groups according to PSG and questionnaire 
results. Group 1: healthy control group (Apnea-hypopnea index (AHI) < 1 and 
history of snoring for less than 3 nights per week), Group 2: mild OSAS group (AHI 
between 1 and 5) and group 3: moderate-to-severe OSAS (AHI > 5). Subjects with 
primary snoring (AHI < 1, history of snoring for > 3 nights per week) were not 
included in this study as there is a potential of misclassifying subjects with upper 
airway resistance syndrome (UARS) as primary snoring. Esophageal pressure 
monitoring is needed to confirm the diagnosis of UARS but it is not routinely used in 
our practice as it is invasive, uncomfortable and often not well tolerated by children. 
4.2.2 Polysomnograhpy 
The overnight PSG was performed in a dedicated sleep laborartory with CNS 
lOOOP polygraph (CNS, Inc., Chanhassen MN). During PSG the following 
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parameters were recorded: electroencephalogram from four leads (C3/A2, C4/A1), 
bilateral electrooculogram, electromyogram of mentalis activity and bilateral anterior 
tibialis. Respiratory movements of the rib cage and abdomen were measured by 
pneumatic effort belt. Electrocardiogram and heart rate were continuously recorded 
from two anterior chest leads. Arterial oxyhaemoglobin saturation (SpO�）was 
measured by an oximeter (Ohmeda 3700 or 3900P, Datex-Ohmeda, Louisville, CO) 
with finger probe. Respiratory airflow pressure signals measured via a nasal catheter 
placed at the anterior nares and connected to a pressure transducer. Snoring was 
measured by a snoring microphone placed near the throat. Body position was 
monitored via a body position sensor. 
All computerized sleep data were further manually edited by experienced PSG 
technologists and clinicians. The terminology and main scoring criteria for the 
respiratory outcomes closely followed the recommendation of the American Thoracic 
Society on PSG scoring (American Thoracic Society, 1996). In brief, Obstructive 
apnea was defined as absence of airflow with persistent respiratory effort lasting 
longer than 2 baseline breaths, irrespective of Sp02 changes. Obstructive hypopnea 
was defined as a reduction of 50% or more in the amplitude of the airflow signal 
with persistent respiratory effort which lasts longer than 2 baseline breaths and 
associated with oxygen desaturation of at least 4% and/or arousals. 
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Apnoea-Hypopoea Index (AHI) was defined as the total number of obstructive 
apnoeic and hypopnoeic episodes per hour of sleep. Oxygen desaturation index (ODI) 
was defined as the total number of dips in arterial oxygen saturation greater than 4% 
per hour of sleep. Arousal was defined as an abrupt shift in EEG frequency during 
sleep, which may include theta, alpha and/or frequencies greater than 16 Hz but not 
spindles, with 3 to 15 seconds in duration. In REM sleep, arousals were scored only 
when accompanied by concurrent increases in submental EMG amplitude. Arousal 
index (Arl) was defined as the total number of arousals per hour of sleep. Score of 
Epworth Sleepiness Scale (ESS), which ranges from 0 to 24 with scores of 10 or 
higher indicating excessive daytime sleepiness was completed by the parents. 
4.2.3 Ambulatory Blood Pressure Measurement (ABPM) 
Ambulatory BP (ABP) was monitored on the same day as overnight PSG using 
an oscillometric monitor (SpaceLabs 90217, SpaceLabs Medical, Redmond, 
Washington, USA), which was validated for use in children. Systolic BP (SBP), 
diastolic BP (DBP) and mean arterial BP (MAP) were measured hourly during the 
period starting from 2130 to 0700 and every 30 minutes out of this period. The 
proper cuff placed in the non-dominant arm was chosen according to the length of 
the arm of the subject. The exact cutoff time dividing wake BP and sleep BP was 
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defined individually according to the polysomnographic tracings. Recordings were 
included in the analysis when they possessed a minimum of 7 successful readings 
during active wakefulness and at least 7 successful readings during sleep. Individual 
mean SBP, DBP and MAP were calculated for wake and sleep periods. All mean BP 
variables were converted into BP z score using the L, M and S reference values 
(relative to gender and height) published by Wuhl E. et al. (2002) as no local normal 
reference is available. Elevated BP and hypertension were defined as mean BP values 
> 90th and percentile of the ABP norm of Wuhl et al. respectively. 
4.2.4 Statistical Analysis 
All continuous data were expressed as mean 士 SD unless otherwise specified. 
Demographic, polysomnographic, BP values and BP z scores were compared using 
one-way analysis of variance (ANOVA) with post-hoc pair-wise comparisons using 
Tukey or Games-Howell method for multiple comparison adjustments depending on 
the agreement of the assumption of variances. As some of the polysomnographic data 
were skewed and contained zero or extreme values, these variables were 
log-transformed (natural log [x + 0.1]). Chi-square tests were performed to 
investigate the difference in proportions between groups. Multiple chi-square tests 
with adjusted p-value (significant at < 0.016) were used for multiple pair-wise 
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comparisons. 
Stepwise linear regression analyses and multiple linear regression analyses were 
performed to assess the relationship between polysomnographic variables and BP 
measures, while controlling for possible confounders. The following independent 
variables were entered into the stepwise linear regression analyses: age, gender, body 
height, BMI, waist circumference, waist-to-hip ratio, ESS score, log-transformed 
AHI, log-transformed ODI, log-transformed Arl and Sp02 nadir. 
Logistic regression analyses were performed to calculate the odds ratios (OR) of 
different forms of hypertension (systolic or diastolic hypertension during wake or 
sleep) for different severity of OSAS compared to normal control, while adjusting for 
possible confounding factors. 
All the analyses were performed using the SPSS (Statistical Package for the 
Social Science) for Windows version 13.0. 
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4.3 Results 
4.3.1 Subject Characteristics 
Four hundred and sixty-six subjects underwent both PSG and ambulatory BP 
recording. One hundred and eighteen children were classified as primary snorers and 
excluded. Forty-two subjects were excluded owing to the low compliance of BP 
monitoring (< 7 successful readings during wakefulness or sleep). As a result, 306 
subjects were included in the final analysis. 
Demographic, anthropometric and polysomnographic characteristics were 
presented in table 4.1. Compared to normal controls and subjects with a lower AHI, 
subjects with AHI > 5 included a larger proportion of boys with significantly higher 
BMI z score. This moderate-to-severe group also had a greater proportion of subjects 
who were overweight and obese with greater waist circumference than the other two 
groups. As expected, subjects with higher AHI values also had significantly higher 
ODI, Arl and lower Sp02 nadir. 
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Total AHI < 1 1 < AHI < 5 AHI > 5 P value 
N=306 N=127 N=133 N=46 (Trend) 
Demographics and Anthropometrics 
Age, yr 10.44 ±1.68 10.41 土 1.74 10.57 ±1.63 10.12 ±1.62 NS 
Male gender, N (%) 199(65%) 72 (56.7) 92 (69.2) 35 (76.1) 0.008 
Body Height, cm 139.57 ±10.52 138.96 ± 10.40 140.17 ±10.82 139.48 ± 10.13 NS 
Body Weight, kg */** ：36.44±10.61 34.16 土 9.35 37.52 ± 11.45 39.61 ± 10.26 < 0 . 0 0 1 
Body Mass Index, m/kg^*/** 18.36 ±3.39 17.40 ±2.94 18.69 ±3.52 20.07 ± 3.39 < 0 . 0 0 0 1 
BMI z score */**/*** 0.48 土 1.04 0.18 ±0.97 0.56 ± 1.04 1.07 ±0.94 <0.0001 
Normal weight, N (%) 204 (66.7) 103 (81.8) 85 (63.9) 16 (34.8) 
Overweight, N (%) */**/*** 59 (19.3) 16 (12.6) 28 (21.1) 15 (32.6) < 0 . 0 0 0 1 
Obese, N (%) 43 (14.1) 8 (6.3) 20 (15.0) 15 (32.6) 
waist circumference, cm */**/*** 63.74 土 9.51 60.91 土 8.09 64.72 土 9.92 68.70 土 9.52 <0.0001 
hip circumference, cm */** 74.42 ± 9.52 72.48 ± 9.03 75.23 ± 10.03 77.45 ± 8.29 <0.001 
waist-to-hip ratio T l * * * 0.86 士 0.06 0.84 土 0.05 0.86 土 0.05 0.89 土 0.06 < 0 . 0 0 0 1 
Polysomnographies 
ESS score 6.46 ±4.11 6.17 土 4.13 6.62 ± 4.20 6.76 土 3.87 NS 
REM sleep, % 20.97 ±4.11 21.01 ± 3.93 21.00 ± 3.93 20.77 ± 5.08 NS 
SWS, % 22.79 ±5.20 23.08 ± 5.36 22.37 土 5.13 23.23 士 4.95 NS 
Non-SWS, % 56.24 士 5.86 55.92 ± 5.97 56.63 土 5.55 56.01 ± 6.46 NS 
Sleep Efficiency, % 82.06 ± 10.71 82.67 土 10.03 81.33 ± 10.86 82.43 ±12.15 NS 
AHI, /hr */**/*** 2.99 ±6.44 0.27 士 0.30 2.20 ± 1.05 12.80 ±12.51 < 0 . 0 0 0 1 
ODI, /hr */**/*** 1.28 ±3.78 0.29 ± 0.43 0.74 ± 1.04 5.54 ± 8.44 <0.0001 
Arl, /hr */**/*** 7.75 ± 4.42 6.06 ±2.50 7.56 ± 3.20 12.98 ±6.98 <0.0001 
Sp02 nadir, % */**/*** 91.51 土 3.17 92.42 ±2.11 91.55±2.63 88.91 ±5.12 < 0 . 0 0 0 1 
Table 4.1. Demographic, anthropometric and polysomnographic data of 
different severity groups of OSAS. BMI denotes body mass index; AHI, 
apnea-hypopnea index; ODI, oxygen desaturation index; Arl, arousal index; SpOi, 
oxyhemoglobin saturation; REM, rapid eye movement; SWS, slow wave sleep. 
* p < 0.05, Normal group vs Mild OSAS group 
** p < 0.05, Normal group vs Moderate-to-severe OSAS group 
*** p < 0.05, Mild OSAS group vs Moderate-to-severe OSAS group 
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Total A H I S 1 1 < AHI < 5 AHI > 5 P 
N=306 N=127 N=133 N=46 (Trend) 
W a k e BP parameters 
WSBP, m m H g **/*** 112.49 土 8.42 110.82 ± 8.32 112.62 土 8.03 116.73 土 8.43 <0.0001 
WDBP, m m H g **!*** 71.62 ± 5.06 70.76 ± 5.01 71.59 ± 4 . 9 4 74.06 ± 4.83 <0.001 
WMAP, mmHg **/*** 85.06 ± 5.37 84.08 ± 5 , 1 8 84.98 ± 5.15 87.99 土 5.59 <0.0001 
W S B P z score **/*** -0.09 ± 1.06 -0.28 ± 1 . 0 5 -0.10 ± 1.00 0.47 土 1.06 <0.0001 
W D B P z score **/*** -0.06 ± 0.84 -0.20 ± 0.82 -0.07 ± 0.82 0.34 ± 0.84 <0.001 
W M A P z score **/*** 0.07 土 0.81 -0.06 ± 0.76 0.05 ± 0.77 0.53 土 0.90 <0.001 
#Elevated W S B P , N (%) **/*** 30 (9.8) 9 (7.1) 10 (7.5) 11 (23.9) 0.007 
#WSBP hypertension, N (。/。） 17(5 .6) 5 (3.9) 7 (5 .3 ) 5 (10 .9 ) NS 
^Elevated W D B P , N (%) 20 (6 .5 ) 6 (4 .7 ) 10(7 .5) 4 (8 .7 ) NS 
#WDBP hypertension, N (%) 11 (3.6) 2 (1.6) 6 (4.5) 3 (6.5) NS 
Table 4.2. Group comparisons of wake BP measures. W S B P denotes wake systolic 
blood pressure; W D B P , wake diastolic blood pressure; W M A P , wake mean arterial 
pressure; N S , not significant. 
* p < 0.05, Normal group vs Mild O S A S group 
** p < 0.05, Normal group vs Moderate-to-severe O S A S group 
*** p < 0.05, Mild O S A S group vs Moderate-to-severe O S A S group 
# p < 0.016 was considered to be significant in multiple pairwise comparison 
WSBP W D B P 
> 90 percentile > 95 percentile > 90 percenti le > 95 percentile 
(N=30) (N=17) (N=20) (N=11) 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
K A M I < 5 adjusted for 
age & gender 1.069 (0 .416 -2 .744 ) 1.492 (0 .454-4 .905) 1.447 (0 .504 -4 .156 ) 2.479 (0 .479- 12.841) 
age, gender & BMI 0.864 (0 .319 -2 .248 ) 1.294 (0 .384-4 .354) 1.134 (0 .379 -3 .390 ) 2.070 (0 .379- 11.292) 
age, gender, BMI & waist 0.799 (0.298 - 2.143) 1.255 (0.371 -4 .247) 1.139 (0.378 - 3.428) 2.232 (0.401 - 12.431) 
AHI > 5 adjusted for 
a g e & g e n d e r 3.943 (1.491 - 10.427) 3.097 (0.831 - 11.542) 1.711 (0.450 - 6.508) 3.737 (0.578 - 24.150) 
age, gender & BMI 2.364 (0.828 -6 .747) 2.066 (0.508 - 8.405) 1.061 (0.254 -4 .430) 2.700 (0.366 - 19.901) 
age, gender, BMI & waist 2.116 (0.731 - 6.126) 1.916 (0.463 -7 .930) 1.068 (0.252 -4 .522) 2.955 (0.387 - 22.547) 
Table 4.3. Adjusted Odds ratios (OR) and 95% confidence intervals (95% CI) of 
elevated BP (> percentile) and hypertension (> percentile) for different 
AHI categories compared to the normal control. Abbreviations as table 4.1 and 
4.2. 
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4.3.2 Blood Pressure during Wakefulness 
Subjects with higher AHI values had significantly higher wake SBP (WSBP), 
wake DBP (WDBP) and wake MAP (WMAP). Post hoc pair-wise comparisons 
showed that the moderate-to-severe OSAS group had significantly higher WSBP, 
WDBP and WMAP than both the normal control and mild OSAS groups, while no 
significant differences were found between the normal group and the mild group. 
The results remained the same after converting the wake BP parameters into z scores 
(adjusting for gender and height). Furthermore, compared to those with lower AHI 
values, subjects with AHI greater than 5 included a greater proportion having 
elevated WSBP (table 4.2). In the logistic regression analyses adjusted for only age 
and gender, moderate-to-severe OSAS group had a higher odds ratio of elevated 
WSBP when compared to the normal control group. However, after adjustment for 
BMI and waist circumference, significant difference in the risk of elevated WSBP 
was no longer demonstrated (table 4.3). 
Stepwise linear regression analyses showed that WSBP was predicted by a 
model (p < 0.0001) that included male gender (p = 0.032), waist circumference (p < 
0.0001) and log-transformed AHI (p = 0.037) while WDBP were predicted by a 
model (p < 0.0001) including male gender {p = 0.008), waist circumference {p < 
0.0001) and log-transformed ODI (p = 0.001). WMAP was also predicted by a model 
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{p < 0.0001) similar to that of WDBP (male gender, p = 0.021; waist circumference, 
p < 0.0001; log-transformed ODlp = 0.001). (table 4.4) 
Multiple linear regression analyses showed that the associations between 
polysomnographic parameters and the wake BP parameters were partially explained 
by BMI and waist circumference. Among AHI, ODI and Arl, ODI had the strongest 
association with wake BP parameters after adjustment for age, gender, body height, 
BMI and waist circumference, while the associations between Arl and wake BP 
parameters became insignificant after the same adjustment. The strength of 
associations with AHI was intermediate between ODI and Arl. (table 4.5) 
WSBP WDBP WMAP 
Independent predictor(s) (3 (SE) Sig. (3 (SE) Sig. (3 (SE) Sig. 
Male gender 1.923 (0.894) 0.032 1.561 (0.584) 0.008 1.383 (0.594) 0.021 
Waist circumference 0.385 (0.046) <0.0001 0.065 (0.030) 0.032 0.169 (0.031) <0.0001 
Log-transformed AHI 0.623 (0.297) 0.037 / / / / 
Log-transformed ODI / / 0.742 (0.225) 0.001 0.752 (0.229) 0.001 
Sig. of the model <0.0001 <0.0001 <0.0001 
Table 4.4. Stepwise linear regression analysis of BP measures during 
wakefulness. Age, gender, body height, body mass index (BMI), waist 
circumference, waist-to-hip ratio, score of Epworth Sleepiness Scale (ESS), 
log-transformed AHI, log-transformed ODI, log-transformed Arl and SpO: nadir 
were put into the stepwise regression analyses. (3 (SE) denotes beta coefficient 
(standard error). Abbreviation as table 4.1 and 4.2. 
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WSBP WDBP WMAP 
Log-transformed AHI adjusted for... p (SE) Sig. (3 (SE) Sig. p (SE) Sig. 
(None) 1.431 (0.311) <0.0001 0.678 (0.189) 0.0004 0.892 (0.199) <0.0001 
Age, Gender & Body height 1.138 (0.301) 0.0002 0.559 (0.192) 0.004 0.743 (0.198) 0.0002 
Age, Gender, Body height & BMI 0.600 (0.297) 0.044 0.486 (0.200) 0.016 0.524 (0.203) 0.010 
Age, Gender, Body height, BMI & Waist 0.575 (0.298) 0.054 0.471 (0.201) 0.020 0.505 (0.204) 0.014 
Log-transformed ODI adjusted for... 
(None) 1.358 (0.371) 0.0003 0.878 (0.222) <0.0001 1.058 (0.235) <0.0001 
Age, Gender & Body height 1.317 (0.348) 0.0002 0.843 (0.219) 0.0001 1.030 (0.227) <0.0001 
Age, Gender, Body height & BMI 0.725 (0.341) 0.034 0.777 (0.228) 0.0007 0.802 (0.232) 0.0006 
Age, Gender, Body height，BMI & Waist 0.699 (0.342) 0.042 0.762 (0.229) 0.001 0.782 (0.232) 0.0009 
Log-transformed Arl adjusted for... 
(None) 2.217 (0.966) 0.022 1.289 (0.580) 0.027 1.555 (0.615) 0.012 
Age, Gender & Body height 2.103 (0.906) 0.021 1.240 (0.571) 0.031 1.494 (0.596) 0.013 
Age, Gender, Body height & BMI 1.367 (0.850) 0.109 1.111 (0.574) 0.054 1.174 (0.583) 0.045 
Age, Gender, Body height, BMI & Waist 1.292 (0.854) 0.131 1.066 (0.576) 0.065 1.113 (0.585) 0.058 
Table 4.5. Multiple linear regression analyses showing the association between 
polysomnographic parameters and the wake BP parameters before and after 
adjustment for demographic and anthropometric variables. (3 (SE) denotes beta 
coefficient (standard error). Other abbreviations as table 4.1 and 4.2. 
4.3.3 Blood Pressure during Sleep 
One-way A N O V A showed that subjects with higher AHI values had 
significantly higher SBP (SSBP), D B P (SDBP) and M A P (SMAP) during sleep 
compared to controls. This finding remained the same after converting the sleep BP 
parameters into z scores (adjusting for gender and height). Furthermore, compared to 
controls and those with lower AHI values, subjects with AHI > 5 included a 
significantly greater proportion of subjects with sleep systolic and diastolic 
hypertension, (table 4.6) 
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Total AHI S 1 1 < AHI < 5 AHI > 5 P 
N=306 N=127 N=133 N=46 (Trend) 
Sleep BP parameters 
SSBP, mmHg* / * * 101.15 ± 8.97 99.13 ± 9 . 1 2 101.71 ± 8.02 105.09 ± 9 . 7 6 <0.0001 
SDBP, mmHg* * 59.26 土 5.67 58.31 ± 5.97 59.54 ± 4 . 9 4 61.10 ± 6 . 3 5 0.003 
SMAP, mmHg* / * * 74.50 ± 5.72 73.16 ± 5.97 75.02 ± 4.87 76.69 ± 6.43 <0.001 
SSBP z score** 0.38 ± 1.05 0.15 ± 1.09 0.44 ± 0.92 0.84 ± 1 . 1 0 <0.0001 
S D B P z score** 0.66 土 0.93 0.51 土 0.98 0.71 土 0.82 0.93 土 1.04 0.006 
S M A P z score*/** 0.78 ± 0.82 0.59 ± 0.87 0.85 ± 0.69 1.08 ± 0 . 9 1 <0.001 
#Beva ted SSBP, N (� / o广 54 (17.6) 18 (14.2) 22 (16.5) 14 (30.4) 0.029 
*SSBP hypertension, N(%)**/*** 37 (12.1) 13 (10.2) 11 (8.3) 13 (28.3) 0.015 
#Elevated SDBP, N(。/。） 69 (22.5) 27 (21.3) 27 (20.3) 15 (32.6) NS 
#SDBP hypertension, N(%)**/*** 48 (15.7) 15 (11.8) 18 (13.5) 15 (32.6) 0.005 
Table 4.6. Group comparisons of sleep BP measures. SSBP denotes sleep systolic 
blood pressure; S D B P , sleep diastolic blood pressure; S M A P , sleep mean arterial 
pressure; AHI, apnea-hypopnea index; N S , not significant. 
* p < 0.05, Normal group vs Mild O S A S group 
** p < 0.05, Normal group vs Moderate-to-severe O S A S group 
***/?< 0.05, Mild O S A S group vs Moderate-to-severe O S A S group 
# ；7 < 0.016 was considered to be significant in multiple pairwise comparison 
SSBP SDBP 
> 90 percenti le > 95 percenti le > 90 percenti le > 95 percentile 
(N=54) (N=37) (N=69) (N=48) 
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) 
1 < A H 1 < 5 adjusted for 
age & gender 1.309 ( 0 . 6 5 7 - 2 . 6 0 8 ) 0.916 ( 0 . 3 8 6 - 2 . 1 7 1 ) 0.906 (0 .495 - 1.659) 1.163 (0 .556 -2 .433 ) 
age, gender & BMI 1.114 ( 0 . 5 4 7 - 2 . 2 6 9 ) 0.845 (0.351 - 2.034) 0.882 (0 .476 - 1.634) 1.140 (0 .539 -2 .414 ) 
age, gender ,已Ml & waist 1.073 ( 0 . 5 2 3 - 2 . 1 9 9 ) 0.828 (0.343 - 2.003) 0.874 (0.471 - 1.624) 1.131 (0 .533 -2 .400 ) 
AHI > 5 adjusted for 
a g e & g e n d e r 3 . 2 0 2 ( 1 . 3 9 4 - 7 . 351 ) 5 . 0 2 3 ( 1 . 9 8 0 - 12 . 745 ) 1 . 6 9 6 ( 0 . 7 9 4 - 3 . 6 2 2 ) 3 . 5 3 7 ( 1 . 5 4 2 - 8 . 1 1 0 ) 
age, gender & BMI 2.219 (0 .918 - 5.361) 4.146(1.544 -11.063) 1.594 (0 .714 - 3.561) 3.377 (1.397 -8 .166) 
age, gender, BMI & waist 2.014 (0 .823 -4 .929 ) 3.883 (1.434 - 10.512) 1.561 ( 0 . 6 9 3 - 3 . 5 1 8 ) 3.309 (1.355 - 8.085) 
Table 4.7. Adjusted Odds ratios (OR) and 95% confidence intervals (95% CI) of 
elevated BP (> percentile) and hypertension (> 95(匕 percentile) for different 
AHI categories compared to the normal control. Abbreviations as table 4.1 and 
4.6. 
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In the logistic regression analyses adjusted only for age and gender, subjects 
with AHI > 5 had about 5 times and 3.5 times higher risk for sleep systolic (OR = 
5.023 [95% CI: 1.980-12.745]) and diastolic hypertension (OR 二 3.537 [95% CI: 
1.542-8.110]) respectively when compared to the controls. The Odds ratios were 
reduced to 3.883 (95% CI: 1.434-10.512) and 3.309 (95% CI: 1.355-8.085) 
respectively after adding BMI and waist circumference into the model, (table 4.7) In 
contrast, for the group of AHI between 1 and 5, no significantly increased risk for 
hypertension or elevated BP was found when compared to the controls, (table 4.7) 
SSBP SDBP SMAP 
Independent predictor(s) (3 (SE) Sig. p (SE) Sig. P (SE) Sig. 
Waist circumference 0.220 (0.062) <0.001 / / / / 
Body height 0.200 (0.054) <0.001 / / 0.133 (0.029) <0.0001 
Log-transformed AHI 1.116 (0.315) <0.001 0.670 (0.213) 0.002 0.878 (0.205) <0.0001 
Sig. <0.0001 0.002 <0.0001 
Table 4.8. Stepwise linear regression analysis of BP measures during sleep. Age, 
gender, body height, BMI, waist circumference, waist-to-hip ratio, score of Epworth 
Sleepiness Scale (ESS), log-transformed AHI, log-transformed ODI, log-transformed 
Arl and SpO: nadir were put into the stepwise regression analyses, p (SE) denotes 
beta coefficient (standard error). Other abbreviations as table 4.1 and 4.6 
Stepwise linear regression analyses showed that SSBP was predicted by a model 
ip < 0.0001) that included waist circumference (p < 0.001), body height (p < 0.001) 
and log-transformed AHI (p < 0.001). SDBP was predicted by a model (p = 0.002) 
including only log-transformed AHI (p = 0.002). SMAP was predicted by a model (p 
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< 0.0001) that included body height (p < 0.0001) and log-transformed AHI (p < 
0.0001). (table 8) 
SSBP SDBP SMAP 
Log-transformed AHI adjusted for... P (SE) Sig. B (SE) Sig. (3 (SE) Sig. 
(None) 1.683 (0.329) <0.0001 0.670 (0.213) 0.002 0.954 (0.211) <0.0001 
Age, Gender & Body height 1.481 (0.311) <0.0001 0.611 (0.218) 0.005 0.868 (0.210) <0.0001 
Age, Gender, Body height & BMI 1.146 (0.319) 0.0004 0.650 (0.228) 0.005 0.768 (0.219) 0.0005 
Age, Gender, Body height, BMI & Waist 1.128 (0.321) 0.0005 0.628 (0.229) 0.006 0.750 (0.220) 0.0007 
Log-transformed ODI adjusted for... 
(None) 0.998 (0.400) 0.013 0.318 (0.255) 0.213 0.587 (0.255) 0.022 
Age, Gender & Body height 1.023 (0.369) 0.006 0.297 (0.255) 0.245 0.587 (0.247) 0.018 
Age, Gender, Body height & BMI 0.593 (0.374) 0.114 0.302 (0.266) 0.257 0.439 (0.256) 0.087 
Age, Gender, Body height, BMI & Waist 0.568 (0.375) 0.131 0.275 (0.266) 0.303 0.416 (0.257) 0.106 
Log-transformed Arl adjusted for... 
(None) 3.128 (1.022) 0.002 1.915 (0.647) 0.003 2.140 (0.650) 0.001 
Age, Gender & Body height 3.060 (0.941) 0.001 1.882 (0.646) 0.004 2.099 (0.629) 0.001 
Age, Gender, Body height & BMI 2.544 (0.920) 0.006 1.891 (0.652) 0.004 1.917 (0.629) 0.003 
Age, Gender, Body height, BMI & Waist 2.485 (0.925) 0.008 1.862 (0.654) 0.006 1.860 (0.632) 0.004 
Table 4.9. Multiple linear regression analyses showing the association between 
polysomnographic parameters and the sleep BP parameters before and after 
adjustment for demographic and anthropometric variables. [3 (SE) denotes beta 
coefficient (standard error). Other Abbreviations as table 4.1 and 4.6. 
Multiple linear regression analyses showed that the associations between 
polysomnographic parameters and SSBP or S M A P were partially explained by BMI 
and waist circumference whereas the associations between SDBP and 
polysomnographic parameters were not greatly affected by B M I and waist 
circumference. Among AHI, ODI and Arl, AHI played the most important role in the 
elevated nocturnal BP values even after adjusting for B M I and waist circumference, 
while the associations between ODI and sleep BP parameters became insignificant 
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after the adjustment. The associations between Arl and sleep BP parameters 
remained significant after adjustment was made for BMI and waist circumference, 
however, the associations were weaker than those between AHI and sleep BP 
parameters, (table 4.9) 
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4.4 Discussion 
This study has provided robust evidence for the presence of an association 
between childhood OSAS and blood pressure elevation during both sleep and 
wakefulness. The blood pressure levels appeared to increase with the severity of 
OSAS. To our knowledge, this is the first study to demonstrate elevation of both SBP 
and DBP during both sleep and wakefulness in children with OSAS. 
Our results showed that wake BP elevation reached significance only in the 
group with moderate to severe OSAS (AHI > 5). In contrast, SSBP and SMAP 
elevation reached significance even for the mild OSAS group when compared to the 
normal controls. Our results also documented that subjects with AHI > 5 had a 
significantly higher risk for nocturnal hypertension (> 95 percentile) but not daytime 
hypertension or elevated daytime BP after adjustment was made for age, gender, 
BMI and waist circumference. Similarly, a recent study that measured 24-hour 
ambulatory BP showed that children with AHI > 5 had a significantly higher SDBP 
than those with lower AHI, whereas no significant difference in WDBP could be 
found (Leung LCK. et al., 2006). This may suggest sleep blood pressure in children 
is more liable to elevation as a result of obstructive sleep apnea, when compared to 
wake blood pressure. Similar finding was also reported in an adult study which 
demonstrated that nocturnal hypertension was the more frequent pattern of 
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hypertension seen in patients with newly diagnosed OSAS (Baguet JP. et al., 2005). 
The elevation of nocturnal BP was believed to be caused by apnea/hypopnea-induced 
acute responses such as hypoxemia, negative intrathoracic pressure and arousals, 
whereas the daytime BP elevation was attributed to the sympathetic activation 
carried over from nighttime to daytime, together with other chronic effects of OSAS 
such as glucose intolerance (Ip MS. et al., 2002) and inflammation (Shamsuzzaman 
ASM. et al., 2002). This study was a population-based study including subjects with 
a relatively mild OSAS. In addition, compare to adults, children with OSAS tend to 
have had a shorter duration of illness. As a result, elevation of daytime BP is less 
prominent in childhood OSAS when compared to the nocturnal BP elevation caused 
by the acute insults of apneas and hypopneas. This emphasizes the importance of 
nocturnal BP measurement in children suspected to have OSAS. 
The diagnostic criterion of OSAS in children has not yet been unified. Marcus 
et al suggested that less than one apnea per hour of sleep should be considered 
statistically normal (Marcus CL. et al” 1992). However, this definition did not take 
partial upper airway obstruction into account. Our previous study showed that the 
diagnostic cutoff level of using AHI > 5 per hour of sleep had the best correlation 
with obstructive apnea > 1 per hour of sleep (Li AM. et al” 2004). Witmans et al 
proposed that children with an AHI < 1.5 per hour of sleep to be considered as 
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statistically normal (Witmans MB. et al., 2003). More recently, it was suggested that 
an AHI > 1 per hour of sleep was abnormal (Traeger N. et al., 2005; Uliel S. et aL, 
2004). However, the cutoff value of AHI associated with complications has not yet 
been determined in children. In our cohort, subjects with AHI > 5 had a significantly 
higher risk of nocturnal hypertension even after adjusting for age, gender, BMI and 
waist circumference, while there was no such difference between the mild OSAS 
group (AHI between 1 and 5) and the controls. This has provided evidence to support 
that AHI > 5 may be a better diagnostic cutoff value of childhood OSAS when 
compared to AHI > 1, at least based on the outcome of blood pressure, although the 
definition of hypertension in this study was only based on population distribution 
instead of true cardiovascular risk. Using AHI > 1 as the cutoff level may lead to 
over-diagnosis of children with OSAS. 
The association between OSAS and systemic hypertension may be explained by 
different mechanisms. Of these, the repetitive arousals from sleep, which play an 
important role in opening the obstructive airway, and the recurrent hypoxic events, 
caused by intermittent airway occlusion, were supposed to play the most important 
role. Both of them were thought to mediate sympathetic activation that may 
over-spill into daytime leading to hypertension during the day. Our findings showed 
that of these two mechanisms, nocturnal hypoxemia was more closely associated 
69 
Ambulatory BP in Children with OSAS 65 
with daytime BP elevation while recurrent arousals, resulting in sleep fragmentation, 
was more closely related to the increase in BP levels during sleep. This is logical, 
although arousals can help to resume breathing from apnea, not all arousals are 
caused by a respiratory event. Since arousal itself may also increase nocturnal BP 
level temporarily, it is reasonable that Arl independently associated with nocturnal 
but not daytime BP levels. In contrast, oxyhemoglobin desaturation during sleep is 
mainly caused by obstructive apnea or hypopnea. Thus, it makes sense that ODI 
associated well with daytime BP levels. Our results are consistent with a previous 
adult study which suggested that nocturnal hypoxemia, when compared to recurrent 
arousals from sleep, was more closely associated with the sympathetic activation that 
spills over at least into the first hour or so after waking up from sleep (Peled N. et aL, 
1998). Another study also reported that in a canine model of OSAS, there was 
sustained daytime hypertension that gradually appeared within 2-5 weeks after the 
dogs were exposed to recurrent apneas. In contrast, recurrent arousals from sleep 
without airway occlusion did not result in daytime hypertension (Brooks D. et al., 
1997). However, previous pediatric studies did not report similar result. Leung LCK. 
et al. (2006) demonstrated that ODI was a better independent predictor of sleep 
diastolic BP when compared to Arl, whilst no polysomnographic parameters 
appeared to be associated with wake BP elevation independently. This discrepancy 
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could be explained by their small sample size (N = 96) that was not sensitive enough 
to demonstrate such modest association. 
Obesity increases both cardiovascular risk and risk of OSAS. This makes the 
assessment of the independent role of OSAS on cardiovascular risk very difficult as 
we are seeing more obese subjects suffering from OSAS. Our results supported that 
obesity is one of the confounding factors in the association between OSAS and 
hypertension. However, the cross-sectional design of our study would not allow the 
complex relationship between obesity, OSAS and hypertension to be delineated. 
There are several possible mechanisms: (1) Obesity causes OSAS, then causes 
hypertension; (2) Obesity causes disorders other than OSAS such as insulin 
resistance and hyperleptinemia, then causes hypertension; (3) OSAS causes 
hypertension irrespective of obesity. If mechanism (2) dominates, the analyses 
adjusted for BMI and waist circumference may be appropriate; but when mechanism 
(1) and (3) dominate, the analysis may be subjected to over-adjustment. Thus, the 
real strength of association between OSAS and hypertension may lie between the 
unadjusted estimates and the BMI and waist circumference adjusted estimates. 
BMI and waist circumference partially explained the association between AHI 
and SBP or MAP during both wakefulness and sleep, while BMI and waist 
circumference were not strongly associated with DBP values, especially during sleep 
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(table 4.10). Stepwise linear regression analyses also showed that SDBP was 
predicted by a model including log-transformed AHI only (table 4.8). Furthermore, 
both the linear regression coefficient of different poiysomnographic parameters on 
the prediction of SDBP and the odds ratio of sleep diastolic hypertension were not 
greatly reduced after adjustment for age, gender, BMI and waist circumference was 
made (table 4.7 and 4.9). Thus, our results suggested that SDBP elevation was 
secondary to OSAS and the association was not confounded by obesity. The 
underlying reason is unclear. This finding was in contrast to two previous paediatric 
studies which showed that the elevation of SDBP in children was related to obesity 
(Leung LCK. et al., 2006; Marcus CL. et al., 1998). However, these studies were 
limited by their relatively small sample size and the clinic based subjects that may 
lead to sampling bias. In adults, at least two previous studies have showed that the 
isolated increase in diastolic blood pressure might be the earliest hypertensive change 
associated with OSAS (Baguet JP. et al., 2005; Sharabi Y. et al., 2003). 
Body Mass Index waist circumference 
Pearson Correlation P Pearson Correlation P 
Wake systolic blood pressure 0.462 0.000 0.466 0.000 
Wake diastolic blood pressure 0.143 0.012 0.160 0.005 
Wake mean arterial pressure 0.322 0.000 0.337 0.000 
Sleep systolic blood pressure 0.400 0.000 0.428 0.000 
Sleep diastolic blood pressure 0.041 0.479 0.075 0.191 
Sleep mean arterial pressure 0.255 0.000 0.290 0.000 
Table 4.10. Pearson correlation between BP values and BMI and waist 
circumference. 
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This study provides strong evidence on the association between childhood 
OSAS and hypertension attributed to its study design. First, our study avoided 
sampling bias by recruiting subjects randomly from the community instead of from 
hospital attendants. Second, our study included a normal healthy control group that 
was absent in all other published pediatric series (Amin RS. et al., 2004; Kaditis AG 
et al., 2005; Kohyama J. et al., 2003; Leung LCK. et al., 2006; Marcus CL. et aL, 
1998). A pure normal control group is essential because primary snorers may also 
have at least some degree of flow limitation during sleep and they may also suffer 
from upper airway resistance syndrome (UARS). As it is unknown whether flow 
limitation during sleep and UARS will alter BP levels, primary snorers should not be 
used as controls. In this study, we excluded all primary snorers. Third, this study has 
a large sample size compared to other published studies. As blood pressure varies 
with multiple factors, a large sample size would in theory allow us to draw a more 
powerful conclusion. Finally, we used ambulatory BP recordings rather than causal 
readings to achieve nocturnal BP measurement and avoided white coat hypertension. 
Habitual snoring was usually considered to be the most common symptom of 
OSAS. However, in this study, a small proportion of subjects reported to be 
non-snorers were identified as having mild OSAS (N = 23, 17.3% of the group) and 
moderate-to-severe OSAS (N = 3, 6.5% of the group). This may be resulted from the 
69 
Ambulatory BP in Children with OSAS 69 
imprecise information of snoring history reported by the parents. 
Total AHI < 1 1 < A H I < 5 AHI > 5 P 
N=306 N=127 N=133 N ^ (Trend) 
Non-Snorer，N (。/。） 61 (19.9) 35 (27.6) 23 (17.3) 3 (6.5) 
Occasional Snorer, N (%) 188 (61.4) 92 (72.4) 68 (51.1) 28 (60.9) <0.0001 
Habitual Snorer, N (%) 57 (18.6) 0 (0.0) 42 (31.6) 15 (32.6) 
Table 4.11. Group comparisons of snoring frequency reported by the parents of 
the subjects. 
The major limitation of this study is the low compliance for a full 24-hour BP 
recording. In average, the ABP recordings covered only 18 hours (18.25 士 3.88 
hours). Most of the subjects were not willing to comply with BP measurements over 
a 24-hour period because of school commitments and their relatively healthy 
physical status, having been recruited from the community. As there is currently no 
local ABP norm available, non-local ABP norms published by Wuhl et al. (German 
population) were applied. As a result, the BP z score and the and percentile 
may be subjected to ethnical errors. Besides, a normative data related to outcome was 
lacking. Hypertension defined here can only be considered as statistically abnormal 
giving no information about future cardiovascular risk. Ours was a cross-sectional 
study and intervention was not reported. It is therefore essential to assess whether 
therapy for OSAS would reverse the documented BP changes. 
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4.5 Conclusion 
In conclusion, BP levels during both wakefulness and sleep increased with the 
severity of childhood OSAS. Wake systolic and diastolic BP was correlated with the 
frequency of desaturation during sleep, while sleep systolic and diastolic BP was 
associated with AHI and Arl independent of the effect of obesity. Children with AHI 
greater than 5 had a higher risk for nocturnal hypertension. The findings from this 
study are clinically relevant and important as hypertension is a well-established risk 
factor for future cardiovascular events and children with OSAS are demonstrated to 
be at such risk. Therefore children with symptoms suggestive of OSAS should be 
investigated early and offered intervention. 
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CHAPTER 5 
Cardiac Remodeling and Dysfunction 
in Children with OSAS 
(A Community Based Study) 
5.1 Introduction 
Childhood obstructive sleep apnea syndrome (OSAS) is being increasingly 
recognised and its prevalence among the pediatric population may be as high as 
10.3% (Redline S. et al., 1999). Cardiac remodeling refers to the change in size or 
shape of the heart that usually accompanied with impaired cardiac function. Early 
studies on childhood OSAS have demonstrated that severe disease can lead to 
congestive heart failure (Brouillette RT. et al., 1982; Brown OE. et al., 1988). More 
recent reports have documented the presence of subclinical forms of cardiac/ 
ventricular dysfunction in children with OSAS (Amin RS. et al., 2002; Amin RS. et 
aL, 2005; Sanchez-Armengol A. et al., 2003; Tal A. et al., 1988). This is an 
important observation as there is increasing evidence to suggest ventricular 
dysfunction as an early indicator of cardiac disability and may precede heart failure 
(Redfield MM. et al., 2003). However, these pediatric studies are limited by their 
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small sample size and lack of healthy children as controls. All cases included in these 
studies were recruited from hospital attendants, which may not truly reflect the 
situation in the community. Furthermore, the effect of intervention for OSAS on 
cardiac dysfunction has not been well characterized. The aims of this study were to 
assess cardiac structure and function in a cohort of community based children with 
and without obstructive breathing during sleep and to measure the degree of 
reversibility following intervention. 
5.2 Methods 
5.2.1 Subjects and Study Design 
Subjects for this study were drawn from our on-going childhood OSAS 
epidemiologic study, which involved children aged between 6 and 13 years recruited 
from thirteen randomly chosen schools. Parents of these school children were asked 
to complete a validated OSAS screening questionnaire (Li AM. et al., 2006) that 
stratified children into high or low risk of OSAS. Children were excluded from the 
study if they had an intercurrent upper respiratory tract infection within 4 weeks of 
polysomnography (PSG), suffered from neuromuscular disorder, craniofacial 
anomalies, syndromic disorder, or if they had previously undergone upper airway 
surgery. Anthropometric parameters including weight, height, waist and hip 
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circumferences and causal systolic and diastolic blood pressure (BP) were measured 
on the day of PSG. Body mass index (BMI) was translated to BMI z score according 
to the normal reference values of Hong Kong Chinese children (Leung SS. et al., 
1998). This project included the first 101 consecutive children who gave consent for 
overnight PSG and echocardiographic examination (ECHO). 
All children were referred for ENT assessment and for those diagnosed to have 
OSAS, adenotonsillectomy was offered. Those who refused surgical intervention or 
surgery thought not to be indicated based on pre-determined criteria (small tonsils; 
tonsils not extend beyond the anterior tonsillar pillar and small adenoids; adenoids 
which occupy less than 25% of post-nasal space with minimal OSAS symptoms or 
poorly controlled allergic rhinitis with supine nasal obstruction) were offered nasal 
corticosteroids therapy (mometasone 100 microgram per day) (Berlucchi M. et al., 
2007) and or non-invasive positive pressure ventilation (NIPPV). These subjects then 
underwent repeat PSG and ECHO 6 months after the operation or start of therapy. 
Children with OSAS who refused any form of therapy were also invited to return at 6 
months for repeat assessment. Informed consent was obtained from the parents or 
legal guardian of each child. The study was approved by the institutional ethical 
committee. 
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5.2.2 Polysomnography (PSG) 
All recruited children underwent one standard overnight PSG at a dedicated 
sleep laboratory with CNS lOOOP polygraph (CNS, Inc., Chanhassen MN) as 
described in our previous publication (Li AM. et al., 2004). In this study, we scored 
the presence of both apneas and hypopneas. Briefly, obstructive apnea was defined 
as absence of airflow with persistent respiratory effort lasting longer than two 
baseline breaths, irrespective of SpOi changes. Obstructive hypopnea was defined as 
reduction of airflow of 50% or more with persistent respiratory effort lasting longer 
than two baseline breaths and associated with oxygen desaturation of at least 4% or 
arousals. Apnea-hypopnea index (AHI) was the total number of obstructive apneas or 
hypopneas per hour of sleep. Oxygen desaturation index (ODI) was defined as the 
total number of dips in arterial oxygen saturation greater than 4% per hour of sleep. 
Arousal was defined as an abrupt shift in electroencephalogram frequency during 
sleep, which may include theta, alpha, and/or frequencies greater than 16Hz but not 
spindles, with 3-15 seconds in duration. In REM sleep, arousals were scored only 
when accompanied by concurrent increases in submental electromyogram amplitude. 
Arousal index (Arl) was defined as the number of arousal per hour of sleep. Score of 
Epworth Sleepiness Scale (ESS), which ranges from 0 to 24 with scores of 10 or 
higher indicating excessive daytime sleepiness was also reported by the parents. 
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Control group was defined as subjects with AHI < 1 and snoring frequency < 3 
nights per week. 
5.2.3 Conventional Echocardiography 
ECHO studies were performed using the Vivid 5 system (Vingmed-General 
Electric, Horten, Norway). The examiner was blinded to the subject's clinical status 
and therefore group allocation. LV volumes and ejection fraction (EF) were assessed 
by biplane Simpson's equation using the apical four-chamber and two-chamber views, 
where the length of the ventricular image was maximized. LV mass was measured by 
the Deverevx's method as previously described (Devereux RB. et al., 1986). LV 
mass was divided by subject's height to the power of 2.7 to provide LV mass index 
(LVMI). Left ventricular hypertrophy (LVH) was defined as an LVMI greater than 
95th percentile of healthy children (38.6gW^) (Daniels SR. et aL, 1995). The 
relative wall thickness (RWT) of LV, a measure of concentricity, was calculated as 
the sum of the thickness of the posterior and septal wall divided by LV diastolic 
diameter. A RWT of greater than 95th percentile of healthy control (0.375) that was 
previously reported was used as cutoff to define concentric LV geometry (de Simone 
G. et al., 2005). LV geometry was classified as normal, concentric remodeling, 
eccentric hypertrophy, or concentric hypertrophy as described by before (Ganau A. et 
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al., 1992). Right ventricular end-systolic (RVSVI) and end-diastolic volume 
(RVDVI) index to height and the RVEF were calculated from apical four chambers 
views, using the area-length method (RV volume = 3/Stt[area^/length]). Any 
significant valvular lesion was examined with hemodynamic assessment made. In 
children with tricuspid regurgitation (TR), spectral Doppler profile was used to 
estimate pulmonary artery systolic pressure from the sum of modified Bernoulli 
equation (velocity] x 4) product and estimated right atrial pressure. Diastolic function 
for both ventricles was assessed by measuring the ratio of the peak early diastolic (E) 
and peak atrial (A) velocity from pulse doppler data of tricuspid and mitral valve. 
Left and right ventricular myocardial performance index (MPI) was defined by the 
sum of isovolumic contraction and relaxation times divided by ejection time obtained 
from pulse Doppler data. 
5.2.4 Tissue Doppler Imaging 
At least three consecutive beats were stored, and the images were analyzed 
offline by a customized software package (EchoPac PC, Vingmed-General Electric, 
Horten, Norway). Two-dimensional color tissue Doppler imaging and pulse wave 
tissue Doppler imaging were used to measure longitudinal myocardial velocity at 
basal segment of RV free wall, interventricular septum, and LV free wall in the 
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apical four chamber view. Left ventricular filling pressure was approximated from 
the relationship of E/e’ where E is the pulse wave Doppler velocity of mitral valve 
and e' was the pulse wave tissue Doppler velocity of septal annulus. 
5.2.5 Statistical Analysis 
All continuous data were expressed as mean 士 SD. Demographic, 
anthropometric, polysomnographic and echocardiograhpic data were compared using 
one-way analysis of variance (ANOVA) with post-hoc pairwise comparisons using 
Tukey or Games-Howell method for multiple comparison adjustments, depending on 
the agreement of the assumption of variances. Parameters that were not normally 
distributed were log-transformed to improve the normality. As some of the 
polysomnographic data were skewed and contained some zero values, these variables 
were log-transformed using special formula (natural log [x + 0.1]). Chi-square tests 
were performed to investigate the difference in proportions between groups. Multiple 
chi-square tests with adjusted p-value {p < 0.016) were used for multiple pairwise 
comparisons. 
Stepwise linear regression analyses were performed to identify demographic, 
anthropometric and polysomnographic factors that might predict echocardiographic 
parameters. The following independent variables were entered in the stepwise 
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regression analysis: age, gender, log-transformed BMI, body surface area (BSA), 
systolic BP, diastolic BP, ESS score, log-transformed OAHI, log-transformed ODI, 
log-transformed Arl and Sp02 nadir. Logistic regression analyses were performed to 
estimate the odds ratios (OR) for abnormal LV geometry for different severity of 
OSAS compared to controls, while adjusting for possible confounding factors. 
For the study of treatment effect, paired t-test and McNemar test were used to 
examine the difference within groups. Independent t-test and Chi-square test were 
used to detect the difference at baseline between groups. Mann-Whitney U test was 
used to examine the difference between the change from baseline to follow-up in 
treatment group and that change in non-treatment group. All analyses were 
performed using the SPSS version 13.0. 
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5.3 Results 
5.3.1 Study population 
Children were divided into control group (AHI < 1 and snoring for <3 nights per 
week, n = 35), mild OSAS group (AHI 1 to 5, n = 39), moderate-to-severe OSAS 
group (AHI > 5, n = 27). The demographic and anthropometric data of the three 
groups were shown in table 5.1. No significant difference in all parameters except for 
BMI z score was documented. 
5.3.2 Poiysomnographic Findings 
Significant differences were found in AHI, ODI and SpO] nadir between the 
three groups. For the arousal index, the moderate-to-severe group had a significantly 
higher value than the other two groups, whereas there was no significant difference 
documented between the mild and control groups, (table 5.1) 
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Total AHI< 1 1 < A H I < 5 AHI > 5 
P value 
(N = 101) (N = 35) (N = 39) (N = 27) 
Demographics and Anthropometrics 
Age, yr 9.62 ± 1.86 9.54 ± 1.90 9.68 ± 1.90 9.62 ±1.82 NS 
Male gender, N (%) 74 (73.3) 25 (71.4) 25 (64.1) 24 (88.9) NS 
Body height, cm 135.15 ± 12.25 132.87 ± 11.30 135.67 ± 12.07 137.34 ±13.59 NS 
Body weight, kg 35.70 ±11.61 33.69 ±10.60 34.78 ±11.33 39.64 ±12.70 NS 
BMI, kg/m^ 19.05 ±3.68 18.67 土 3.60 18.43 ±3.73 20.41 ± 3.48 NS 
BMI z score*** 0.82 ± 1.04 0.75 ± 1.05 0.60 ±1.11 1.24 ±0.79 0.039 
已SA，m2 1.14 ±0.22 1.10 ±0.20 1.13 ±0.22 1.21 ±0.25 NS 
Waist-to-hip ratio 0.87 土 0.06 0.87 土 0.05 0.86 土 0.05 0.89 ± 0.08 NS 
Systolic BP, mmHg 104.70 ± 11.68 102.63 土 11.86 104.18 ± 10.46 108,15 ±12.75 NS 
Diastolic BP, mmHg 68.03 土 9.72 67.31 ±9.68 66.92 ± 10.48 70.56 ± 8.42 NS 
Polysomnographies 
ESS score 6.98 ±4.68 5.91 ±4.12 7.59 ±5.19 7.48 ±4.53 NS 
REM sleep, % 20.41 土 4.77 21.36 ±3.86 19.98 ±4.63 19.79 ±5.90 NS 
SWS, % 23.55 ± 5.84 23.88 土 4.65 23.45 ± 6.90 23.27 ± 5.78 NS 
Non-SWS, % 56.04 土 6.58 54.76 土 5.75 56.57 土 6.45 56.93 士 7.67 NS 
Sleep Efficiency, % 81.11 ± 11.18 82.26 土 8.66 80.26 ± 11.03 80.83 ±14.21 NS 
AHI,/hr * “ * “ * * 4.95 ±9.78 0.27 ± 0.34 2.40 ±1.19 14.73 ±15.08 < 0 . 0 0 0 1 
ODI, /hr 2.32 ± 5.98 0.14 ± 0.20 0.75 ± 0.72 7.40 ±10.00 < 0 . 0 0 0 1 
Ar l , /hr 8 .12 ± 5 .67 6 .00 ± 2 .80 6 .82 ± 2 . 9 7 12 .75 ± 8 . 3 5 <0.0001 
Sp02 nadir, % * ' ** ' *** 91.26 ± 3.87 93.57 ±2.17 91.38 ± 1.94 88.07 土 5.32 < 0 . 0 0 0 1 
Table 5.1. Group Comparisons of Demographic, Anthropometric and Poly-
somnographic Parameters. BMI indicates body mass index; BSA, body surface 
area; BP, blood pressure; ESS, Epworth sleepiness scale; REM, rapid eye movement; 
SWS, slow wave sleep; AHI, apnea-hyponea index; ODI, oxygen desaturation index; 
Arl, arousal index; Sp02; oxyhemoglobin saturation. 
* p < 0.05, Normal group vs Mild OSAS group 
** p < 0.05, Normal group vs Moderate-to-severe OSAS group 
< 0.05, Mild OSAS group vs Moderate-to-severe OSAS group 
71 
Cardiac Remodeling and Dysfunction in Children with OSAS 81 
5.3.3 Echocardiographic Findings 
5.3.3.1 Right Ventricle 
RVSVI, RVDVI, EF and MPI were all significantly different between the three 
groups. The control group had significantly smaller RVSVI and higher EF than both 
the mild and moderate-to-severe OSAS groups. For RVMPI, post hoc test showed 
that the moderate-to-severe group had a significantly greater value than the mild and 
control groups (table 5.2). By stepwise regression, log-transformed AHI and BSA 
were found to be independent predictors of RVSVI and RVEF. Log-transformed 
AHI was found to be the only independent predictor of log-transformed RVMPI and 
it explained nearly 20% of variance (table 5.3). By forcing age, gender and 
log-transformed BMI or BSA into the regression model, the contribution of 
log-transformed AHI remained highly significant in the association with RVSVI, 
RVEF and RVMPI {p < 0.001). No significant TR was noted in any of the children. 
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Total A H I < 1 1 < A H I < 5 AHI > 5 p ^ g l u e 
(N = 101) (N = 35) (N = 39) (N = 27) ^ ^ 
Right Ventricle 
R V S V I , c . c . / m * / * * 22.88 土 9.15 18.13 ±8.39 25.50 ± 9.51 25.26 ±7.14 < 0.001 
RVDVI, c.c./m * 49.07 ± 14.96 44.15 ± 13.13 52.53 ± 15.97 50.45 土 14.48 0.045 
RVEF * / ** 0 . 5 3 ± 0 . 1 2 0 . 5 9 ± 0 . 1 1 0.51 ± 0 . 1 2 0 . 4 9 ± 0 . 1 2 0.001 
RVMPI * * / * * * 0.37 ± 0 . 1 2 0.32 ± 0 . 0 9 0.36 ± 0.09 0.46 ± 0 . 1 4 < 0.001 
E/A 1.89 ± 0 . 9 8 1.78 ± 0 . 6 8 1.90 ± 1.14 2.02 ± 1 . 0 8 NS 
Left Ventricle 
LVSVI, c.c./m 22.59 ± 9 . 6 0 22.98 ± 9.83 23.04 土 8.89 21.43 ± 1 0 . 5 2 NS 
LVDVI, c.c./m 65.58 ± 12.83 66.83 ± 13.37 64.03 ± 12.55 66.21 ± 12.78 NS 
LVEF 0.66 ± 0 . 1 1 0.66 ± 0 . 1 0 0.64 土 0.10 0.69 ± 0 . 1 2 NS 
IVSI, cm/m *** 0.56 ± 0 . 0 9 0.56 ± 0.09 0.52 ± 0.09 0.60 ± 0.09 0.004 
LVPWI, cm/m 0.52 土 0.10 0.52 土 0.10 0.50 ± 0.09 0.56 ± 0 . 1 1 NS 
LVMI g/m^ ' 32.64 ± 9.47 32.47 ± 7.78 30.27 ± 7.29 36.29 ± 12.87 0.038 
LVH (LVMI > 38.6 g / m ' ' ) , N (。/。） 22 (21.8) 7 (20.0) 6 (15.4) 9 (33.3) NS 
R W T * * * 0.36 ± 0 . 0 7 0.36 ± 0.07 0.34 ± 0.06 0.39 ± 0.07 0.005 
Concentr ic LV geometry, N ( % ) * * / * * * 35 (34.7) 10 (28.6) 6 (20.5) 17 (63.0) 0.001 
Abnormal LV Geometry, N (%) ** / *** 43 (42.6) 14 (40.0) 9 (23.1) 20 (74.1) < 0.001 
Concentr ic Remodel ing, N (%) 21 (20.8) 7 (20.0) 3 (7.7) 11 ( 4 0 . 7 ) � 
Concentr ic Hypertrophy, N ( % ) 卜 *** 14(13.9) 3 (8 .6 ) 5 (12 .8 ) 6 (22 .2 ) > 0.003 
Eccentric Hypertrophy, N (%) J 8 (7 .9 ) 4 (11 .4 ) 1 (2 .6 ) 3 ( 1 1 . 1 ) , 
LVMPI 0.33 ± 0 . 1 1 0.32 ± 0 . 0 8 0.32 ± 0 . 1 2 0.35 ± 0 . 1 4 NS 
E/A 2.09 ± 0 . 5 4 2.09 ± 0.49 2.17 ± 0 . 6 3 1.95 ± 0 . 4 3 NS 
Deceleration t ime, msec 167.08 ± 4 2 . 4 7 179.25 ± 51.72 159.23 ± 30.82 162.63 ± 4 1 . 7 2 NS 
E / e ’ * * / * * * 9.53 ± 1.79 9.13 ± 1.80 9.27 士 1.37 10.42 ± 2 . 0 5 0.009 
Table 5.2. Group Comparisons of Right and Left Ventricular Structure and 
Function. R V S V I indicates right ventricle systolic volume index to height; R V D V I , 
right ventricle diastolic volume index to height; R V E F , right ventricle ejection 
fraction; R V M P I , right ventricle myocardial performance index; LVSVI, left 
ventricle systolic volume index to height; L V D V I , left ventricle diastolic volume 
index to height; L V E F , left ventricle ejection fraction; IVSI, interventricular septum 
thickness index to height; L V P W I , left ventricle posterior wall thickness index to 
height; L V M I , left ventricle mass index; L V H , left ventricular hypertrophy; R W T , 
relative wall thickness; L V M P I , left ventricle myocardial performance index; E/A, 
ratio of early to late peak transtricuspid or transmitral flow; E/e，，ratio of mitral early 
peak velocity/ mitral annulus early peak velocity. 
* p < 0.05, Normal group vs Mild O S A S group 
** p < 0.05, Normal group vs Moderate-to-severe O S A S group 
*** p < 0.05, Mild O S A S group vs Moderate-to-severe O S A S group 
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RVSVI #RVDVI RVEF #RVMPI 
P (SE) Sig. (3 (SE) Sig. (3 (SE) Sig. P (SE) Sig. 
#AHI 1.46 (0.41) 0.0006 / / -0.03 (0.01) 0.0002 0.09 (0.02) < 0.0001 
BSA 22.71(3.12) < 0.0001 0.70 (0.12) < 0.0001 -0.16 (0.05) 0.002 / / 
R square 0.459 0.251 0.255 0.197 
Table 5.3. Stepwise linear regression analysis of RV structural and functional 
parameters. (3 (SE) denotes beta coefficient (standard error). Other abbreviations as 
in table 5.1 and 5.2. 
# The variables are log-transformed 
5.3.3.2 Left Ventricle 
The LV relative wall thickness (RWT) and the interventricular septal thickness 
index to height (IVSI) were significantly higher in the moderate-to-severe group 
when compared to the mild and control groups. Similar trend was observed for 
LVMI and posterior wall thickness index to height (LVPWI) although subgroup 
comparisons showed no significant difference. The moderate-to-severe group also 
had a greater proportion of subjects having concentric LV geometry and abnormal 
LV geometry when compared to the mild and control group. The details of the 
different subtypes of LV geometry were shown in table 5.2. No significant difference 
in LV systolic function was found between different severities of OSAS. For 
diastolic function parameters, there was no significant difference in E/A and 
deceleration time between groups, however E/e', a marker of LV filling pressure 
increased with increasing severity of OSAS. 
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Stepwise linear regression results showed that IVSI was independently 
associated with DBP and log-transformed ODI (table 5.4). By forcing age, gender 
and log-transformed BMI into the model of IVSI, log-transformed ODI remained 
significantly associated with log-transformed IVSI [p (SE) = 0.013 (0.006), p = 
0.025]. Log-transformed AHI was found to be the only independent variable 
associated with E/e，. However, the association became insignificant when age, 
gender and log-transformed BMI were forced into the model [p (SE) = 0.204 (0.105), 
；7 = 0.056]. 
LVMI #RWT IVSI LVPWI E/e’ 
P (SE) Sig. (3 (SE) Sig. (3 (SE) Sig. 3 (SE) Sig. (3 (SE) Sig. 
#BMI 33.14 (7.38) < 0.0001 0.25 (0.10) 0.013 / / 0.11 (0.05) 0.037 / / 
BSA -29.16 (6.05) < 0.0001 / / / / / / / / 
DBP 0.26 (0.09) 0.007 / I 0.002 (0.001) 0.029 / / / / 
#ODI / / / / 0.015 (0.006) 0.009 / / / / 
#AHI / / / / / / / / 0.27 (0.10) 0.010 
R square 0.272 0.061 0.123 0.043 0.065 
Table 5.4. Stepwise linear regression analysis of LV structural and functional 
parameters. (3 (SE) denotes beta coefficient (standard error). Other abbreviations as 
in table 5.1 and 5.2. 
# The variables are log-transformed 
Multivariate logistic regression analyses were used to examine whether the 
severity of OSAS was associated with the presence of LVH, concentric LV geometry 
or abnormal LV geometry. There were no significant differences between the risks of 
LVH, concentric LV geometry and abnormal LV geometry in the mild OSAS group 
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compared to controls. But for the moderate-to-severe group, the risks for concentric 
L V geometry and abnormal L V geometry were about 4.25 times (OR = 4.250 [95% 
CI: 1.456 - 12.408], p = 0.008) and 4.29 times (OR = 4.286 [95% CI: 1.434 -
12.806], p = 0.009) higher when compared to controls before adjusting for any 
confounders. The odds ratios were reduced but remained significant after adjustment 
for age, gender, B S A or log-transformed B M I was made, (table 5.5) 
LV hypertrophy Concentric LV geometry Abnormal LV geometry 
Control variables 
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value 
K A M I < 5 
(None) 0.727 ( 0 . 2 1 9 - 2 . 4 1 7 ) 0.603 0.645 ( 0 . 2 2 2 - 1.878) 0.421 0.450 ( 0 . 1 6 5 - 1.231) 0.120 
a g e & g e n d e r 0.721 ( 0 . 2 1 5 - 2 . 4 2 0 ) 0.597 0.584 ( 0 . 1 9 3 - 1.767) 0.341 0.430 ( 0 . 1 5 5 - 1.190) 0.104 
BSA 0.750 ( 0 . 2 2 4 - 2 . 5 0 9 ) 0.641 0.580 ( 0 . 1 9 3 - 1.743) 0.332 0.443 (0.161 - 1.217) 0.114 
#BMI 0.738 (0.221 - 2 . 4 6 5 ) 0.621 0.652 ( 0 . 2 1 9 - 1 . 9 4 5 ) 0.443 0.452 ( 0 . 1 6 4 - 1 . 2 5 1 ) 0.126 
age, gender & BSA 0.735 ( 0 . 2 1 8 - 2 . 7 4 2 ) 0.618 0.563 ( 0 . 1 8 5 - 1.713) 0.312 0.426 ( 0 . 1 5 4 - 1.182) 0.101 
age, gender & # B M I 0.762 ( 0 . 2 2 3 - 2 . 6 0 2 ) 0.665 0.586 (0.192 _ 1.793) 0.349 0.437 (0.156 _ 1.222) 0.115 
AHI > 5 
(None) 2.000 ( 0 . 6 3 2 - 6 . 3 2 7 ) 0.238 4.250 (1.456 - 1 2 . 4 0 8 ) 0.008 4.286 ( 1 . 4 3 4 - 1 2 . 8 0 6 ) 0.009 
a g e & g e n d e r 2.130 ( 0 . 6 5 5 - 6 . 9 2 9 ) 0.209 5.002 (1.597 -15 .666 ) 0.006 4.639 (1.516-14.194) 0.007 
BSA 2.281 ( 0 . 6 9 6 - 7 . 4 7 2 ) 0.173 3.583 (1.184 - 1 0 . 8 4 4 ) 0.024 4.105 (1.351 - 1 2 . 4 7 0 ) 0.013 
#BMI 1.791 ( 0 . 5 5 3 - 5 . 8 0 6 ) 0.331 3.584 (1.192 - 1 0 . 7 7 5 ) 0.023 3.769 (1.237 - 1 1 . 4 8 6 ) 0.020 
age, gender & BSA 2.390 ( 0 . 6 9 3 - 8 . 2 3 7 ) 0.168 4.413 (1.362 - 1 4 . 3 0 2 ) 0.013 4 . 4 4 5 ( 1 . 4 0 4 - 1 4 . 0 7 8 ) 0.011 
age, gender & # B M I 1.830 ( 0 . 5 4 9 - 6 . 1 0 1 ) 0.325 4 . 3 5 4 ( 1 . 3 6 3 - 1 3 . 9 1 2 ) 0.013 4 . 0 8 5 ( 1 . 3 0 9 - 1 2 . 7 5 5 ) 0.015 
Table 5.5. Odds ratio (OR) and 95% confidence intervals (adjusted for different 
factors) of LV hypertrophy, concentric LV geometry and abnormal LV 
geometry for different AHI categories compared to the normal control. 
Abbreviations as in table 5.1 and 5.2. 
# B M I is log-transformed. 
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5.3.4 Treatment Effect 
Eight children diagnosed to have OSAS underwent adenotonsillectomy and 9 
children received nasal steroid therapy and together they formed the treatment group. 
No children opted to receive NIPPV in our study. The non-treatment group consisted 
of 19 children who did not receive treatment for OSAS. Both the treatment and 
non-treatment group underwent reassessment PSG and ECHO at six months from 
baseline. The treatment group had significantly higher PSG findings than the 
non-treatment group (table 5.6). 
At six months there was significant increase in anthropometric parameters in 
both treatment and non-treatment group attributed by growth (table 5.6), but there 
was no difference in the increase observed between the two groups. The treatment 
group showed improvement in AHI, ODI and ESS that was not observed in the 
non-treatment group. Significant reductions in RVMPI, IVSI, LVMI and E/e’ from 
baseline to 6 months follow up were noted in the treatment group (table 5.7). 
Changes in RVMPI (mean reduction = 0.119 [95% CI: 0.042 — 0.197] versus 0.016 
[95% CI: -0.059 - 0.091], p 二 0.035), IVSI (mean reduction = 0.070cm [95% CI: 
0.013 - 0.128] versus mean elevation = 0.030cm [95% CI: -0.019 - 0 . 078 ] ,= 0.003) 
and E/e'(mean reduction = 1.44 [95% CI: 0.40 - 2.48] versus mean elevation = 0.44 
[95% CI: -0.40 - 1.28], p = 0.004) after 6 months were significantly different in the 
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treatment and the non-treatment groups (table 5.7). Change in AHI was positively 
associated with changes in RVMPI (r = 0.352,厂二 0.032), IVSI (r = 0.435,/? = 0.007) 
and E/e丨（r = 0.427, ；？ = 0.008). 
Treatment Group (N = 17) 户卞 Non-treatment Group (N = 19) ^ 卞 
Pre Post Pre Post 
Anthropometrics 
Body height, cm 134.8 ±14.14 143.74 ±12.77 < 0 . 0 0 0 1 133.95 ±13.38 145.53 土 13.64 < 0 . 0 0 0 1 
Body weight, kg 38.31 土 14.60 46.05 ±16.38 < 0 . 0 0 0 1 33.34 ± 9.72 42.46 ±13.06 < 0 . 0 0 0 1 
BMI, kg/m^ 20.39 土 4.19 21.63 ±4.75 0.014 18.19 土 2.99 19.60 ±3.85 <0.001 
BMI z score 1.23 士 0.99 1.23 ±1.00 NS 0.72 ± 1.08 0.69 ±1.18 NS 
BSA, m^ 1.17 ±0.27 1.33 ±0.28 <0.0001 1.11 ±0.21 1.30 ±0.25 <0.0001 
Waist-to-hip ratio 0.89 ± 0.06 0.86 ± 0.07 NS 0.88 ± 0.04 0.85 ± 0.05 NS 
Systolic BP, mmHg 110.06± 14.43 113.76± 12.93 NS 104.47±9.71 111.58± 11.77 0 . 0 2 5 
Diastolic BP, mmHg 68.7 ± 9.89 68.82 ± 7.22 NS 67.84 ± 7.45 68.6 士 7.75 NS 
Polysomnographies 
ESS score 8.41 ±4.24 4.35 ± 3.64 0.010 8.26 ± 5.38 7.53 ±4.90 NS 
REM sleep, % 18.99 ±6.16 20.09 ± 3.71 NS 20.26 ± 3.57 20.85 ± 3.78 NS 
SWS, % 22.52 土 5.31 21.78 土 3.92 NS 23.37 ± 7.31 20.27 土 4.31 NS 
NSWS, % 58.49 土 7.80 58.13 ±6.42 NS 56.37 ± 6.96 58.88 ± 4.77 NS 
Sleep Efficiency, % 76.58 ± 15.36 79.88 ±12.45 NS 83.18 ±7.49 81.07 ±11.79 NS 
AHI, /hr* /# 16.75 ± 18.43 4.59 ± 4.33 <0.001 2.85 ±1.61 4.14 ±3.87 NS 
ODI, /hr*/# 8.89 ±12.16 1.44 ±2.09 < 0 . 0 0 1 1.40 ±2.08 1.27 ±1.47 NS 
Arl, /hr*/# 13.10 ±9.70 10.48 ±3.41 NS 7.07 ± 2.37 9.38 ±4.13 0.020 
Sp02 nadir, % */# 87.06 ± 5.84 90.7 ± 3.58 NS 90.68 ±1.63 90.63 土 3.11 NS 
Table 5.6. Intra- and inter-group comparisons for the anthropometric and 
polysomnographic parameters of the treatment group and the non-treatment 
group. Abbreviations as in table 5.1. 
t F - value between the baseline and the 6 months follow-up within group 
* F < 0.05 indicates significant difference between baseline value of treatment 
and non-treatment groups 
# P < 0.05 indicates significant difference in the change from baseline to 
follow-up between treatment and non-treatment group 
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Treatment Group (N = 17) 户卞 Non-treatment Group (N = 19) 户卞 
Pre Post Pre Post 
Right Ventricle 
RVSVI, c.c./m 24.04 ±8.99 23.41 ±9.18 NS 24.03 ± 7.53 23.48 ±12.13 NS 
RVDVI, c.c./m 49.33 ± 17.24 49.38 ±15.54 NS 50.20 土 15.59 44.30 土 16.40 NS 
RVEF 0.50 土 0.13 0.53 ±0.10 NS 0.51 ±0.10 0.48 士 0.16 NS 
RVMPI * / # 0.47 ±0.15 0.35 ±0.89 0.005 0.37 ±0.10 0.35 ±0.10 NS 
E/A 1.78 ±0.54 1.95 ±0.92 NS 2.19 ± 1.53 2.42 ±1.00 NS 
Left Ventricle 
LVSVI, c.c./m 22.25 ± 10.62 27.43 ±11.92 NS 22.04 ±8.10 27.34 ±12.56 0.049 
LVDVI, c.c./m 68.03 ±11.61 67.91 ± 16.04 NS 62.28 ± 13.17 65.95 ±15.82 NS 
LVEF 0.68 ±0.12 0.61 ±0.12 NS 0.65 土 0.11 0.60 ±0.11 NS 
I VS / height, cm/m * / # 0.61 ±0.10 0.54 ± 0.08 0.019 0.52 ± 0.08 0.55 ±0.10 NS 
LVPW/height, cm/m 0.57 ±0.11 0.53 ± 0.08 NS 0.51 ± 0.09 0.51 ± 0.07 NS 
LVMI’g/m2 7 36.37 ± 11.50 30.44 ± 7.70 0.038 30.78 ± 8.37 29.02 ±6.85 NS 
LVH, N (%) 6(35.3) 2(11.8) NS 3 (15.8) 2(10.5) NS 
R W T * / # 0.39 士 0.08 0.37 ± 0.05 NS 0.34 ± 0.05 0.36 ± 0.06 NS 
Concentric LV geometry, N (%) * 9 (52.9) 10 (58.8) NS 4(21.1) 8(42.1) NS 
Abnormal LV geometry, N (。/。）* 12 (70.6) 10 (58.8) NS 5 (26.3) 8 (42.1) NS 
L V M P I 0.34 ± 0.13 0.25 ± 0 . 0 9 0.025 0 .35 ± 0.12 0.29 ± 0 . 1 1 0.027 
E/A* 1.88 ±0.35 2.01 ±0.46 NS 2.34 ± 0.78 2.45 ± 0.73 NS 
Deceleration time, msec 166.88 ±44.92 178.47 ±64.31 NS 163.89 士 36.02 154.63 土 35.64 NS 
E / e ’ * / # 10.81 ±2.32 9.38 ± 1.45 0.018 9.36 ±1.21 9.80 ±1.62 NS 
Table 5.7. Intra- and inter-group comparisons for the ventricular 
characteristics of the treatment group and the non-treatment group. 
Abbreviations as in table 5.2. 
卞 P - value between the baseline and the 6 months follow-up within group 
* P < 0.05 indicates significant difference between baseline values of treatment 
and non- treatment groups 
# P < 0.05 indicates significant difference in the change from baseline to 
follow-up between treatment and non-treatment group 
Compared with the control group, the treatment group has shown significantly 
elevated RVSVI (24.04 士 8.99 versus 18.13 士 8.39,;? = 0.024), RVMPI (0.47 士 0.15 
versus 0.32 土 0.09,;? < 0.0001) and E/e，(10.81 士 2.32 versus 9.13 士 1.80,;? = 0.008), 
and significantly reduced RVEF (0.50 士 0.13 versus 0.59 土 0.11, p = 0.011) at 
baseline. After treatment of OSAS, RVMPI (0.35 士 0.89 versus 0.32 士 0.09, p = 
71 
Cardiac Remodeling and Dysfunction in Children with OSAS 89 
0.195) and E/e, (9.38 土 1.45 versus 9.13 士 1.80,;? = 0.515) of the treatment group 
were no longer different from those of the control group, implicating that these 
abnormalities had been reversed by intervention for OSAS. RVEF was improved 
slightly after treatment, however remained significantly smaller than the controls 
(0.53 土 0.10 versus 0.59 土 0.11, p = 0.036), whereas in the non-treatment group, 
RVEF slightly decreased at follow-up. 
The non-treatment group, when compared with the controls, had significantly 
increased RVSVI (24.03 士 7.53 versus 18.13 士 8.39, p = 0.008) and also reduced 
RVEF (0.51 士 0.10 versus 0.59 士 0.11, p = 0.011). In comparison to the treatment 
group, RVEF of the non-treatment group decreased slightly, although not significant, 
at follow-up and remained significantly different from the controls (0.48 ±0 .16 
versus 0.59 士 0.11,;? = 0.003). 
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5.4 Discussion 
In this study we were able to document RV and LV dysfunction and remodeling 
in a cohort of community based children with OSAS. The AHI was demonstrated to 
be a significant independent parameter associated with cardiac dysfunction. 
Following treatment for OSAS, the cardiac abnormalities improved. This finding is 
clinically important as ventricular dysfunction and remodeling is an independent risk 
factor for future cardiovascular disease (Vakili BA. et al., 2001). 
In adults, there were disparate conclusions of previous studies on the effect of 
OSAS on RV function and enlargement. A recent study has shown right ventricular 
dilatation and dysfunction in patients with severe OSAS (Shivalkar B. et al., 2006). 
The findings appeared to be reversed by CPAP therapy (Dursunoglu N. et al., 2006; 
Shivalkar B. et al； 2006). These changes in the right ventricular structure and 
function may be owing to the repetitive elevations of pulmonary artery pressure and 
pulmonary vascular resistance resulting from OSAS. However, in a population-based 
study RV dimensions and RV systolic function measured by ECHO were not shown 
to be significantly different between subgroups with varying OSAS severity (Guidry 
UC. et al., 2001). The pathophysiological mechanisms underlying the occurrence of 
OSAS in children and adults are in many aspects quite different. In the latter, OSAS 
is primarily associated with obesity, and it is well established that obesity and its 
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metabolic complications are risk factors for cardiac abnormalities (Peterson LR. et 
al., 2004; Wong CY. et al., 2004). Thus failing to control for obesity could have 
given conflicting results in the relationship between adult OSAS and cardiac 
dysfunction. 
There were limited studies on RV function in children with OSAS (Brouillette 
RT. et al., 1982; Hunt CE. et al., 1982). In the majority the sample population 
included only children with severe disease (Brouillette RT. et al., 1982; Hunt CE. et 
al., 1982) and cor pulmonale was consistently observed. Our study showed that AHI 
independently correlated with RV function, even after adjusting for age, gender, 
BSA and BMI. This provided evidence that subclinical RV dysfunction already 
exists in children with mild degree of OSAS. Further evidence to support RV 
involvement in childhood OSAS is that RV functions significantly improved after 
intervention as shown in our study as well as that reported by Tal A. et al. (1988). 
Our study has documented that after controlling for age, sex and BMI, children 
with an AHI greater than five had a 4.4-fold and a 4.1-fold increased risk for 
concentric LV geometry and abnormal LV geometry respectively, when compared to 
normal controls. But no significant increased risk for LV hypertrophy was detected 
in the moderate-to-severe group, in comparison to previous study that showed a 
11.2-fold increase (Amin RS. et al., 2002). This is likely to be related to the milder 
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OSAS severity in our cohort. In previous report, the predominant abnormality in LV 
geometry was eccentric hypertrophy in comparison to concentric remodeling in our 
cohort (Amin RS. et al., 2002). For similar degree of LV mass, concentric 
hypertrophy is associated with greater cardiovascular risk (Krumholz HM. et al., 
1995; Muiesan ML. et al., 2007; Verdecchia P. et al., 1996). Increase in preload 
causes LV to dilate and results in eccentric hypertrophy, whilst increase in afterload 
like episodic increase in blood pressure as expected from OSAS should cause 
concentric hypertrophy in the LV wall. Indeed stepwise regression showed diastolic 
BP to be an independent predictor of LVMI and IVS index to height making BP an 
important contributing factor to LV remodeling. We did not have ambulatory BP 
measurements, and in particular BP readings during apneic episodes, hence only 
single daytime BP measurement was used for analysis. This could undermine the 
contribution of episodic increase in BP and therefore afterload in causing concentric 
remodeling. 
Altered LV diastolic filling is expected from concentric hypertrophy, however 
our study did not show a difference in mitral valve E/A between groups. The result 
may be accounted for by the sensitivity of early transmitral velocity (E) to loading 
condition, heart rate, as well as increase LV mass. Transmitral flow in relation to 
tissue diastolic velocity e’ may be a better method in assessing diastolic function 
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(Peterson LR. et al., 2004; Wong CY. et al., 2004) and E/e’ was indeed shown to 
increase with OSAS severity. This is in agreement with another study on left 
ventricular function in children with OSAS where the authors also demonstrated a 
dose-dependent decrease in diastolic function with increased OSAS severity 
(Sanchez-Armengol A. et al., 2003; Wong CY. et al., 2004). 
Adenotonsillectomy in children with OSAS has shown to improve growth, 
neurocognitive function, and nocturnal enuresis (Leiberman A. et al., 2006). Well 
conducted studies that reported on the outcome of OSAS treatment on cardiac 
findings are scarce. Goriir et al showed improvement in RV dimension, LV end 
diastolic diameter, and IVS assessed by echocardiogram after adenotonsillectomy 
(Gorur K. et al., 2001). Unique to our study is the present of a non-treatment group 
that allowed the effect of growth to be taken into account. The mean AHI post 
treatment in the treatment group was 4.59 ±4.33 per hour and despite a significant 
reduction it was still abnormal using the current recommended diagnostic cutoff for 
childhood OSAS. Similar result was reported by Tauman R. et al. (2006), complete 
normalization of PSG parameters was not documented after adenotonsillectomy, and 
children with higher BMI was less likely to have a cure. The effect of nasal steroid is 
expected to be less pronounced (Brouillette RT. et al., 2001). This implies a complex 
pathophysiology behind OSAS in children, and adenoid hypertrophy cannot be the 
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only factor. Albeit the incomplete cure, there was significant improvement in RV and 
LV function and remodeling after treatment. It may be noteworthy that in the 
non-treatment group, RVEF decreased slightly and IVS increased slightly, although 
not statistically significant, after 6 month. In addition, the prevalence of abnormal 
LV geometry in non-treatment increased from 26.3% at baseline to 42.1% at 
follow-up, although not statistically significant owing to the small sample size. This 
reaffirms the importance of early detection and treatment of childhood OSAS. 
The severity of OSAS in our sample population was relatively mild and this was 
likely related to our subject recruitment from the community. The results generated 
from our study are however, important and clinically relevant as abnormal cardiac 
function and structure could already be demonstrated in this community based cohort, 
emphasizing the need to recognize OSAS early in its progression. The non-treatment 
group returning for repeat assessment consisted of children with mild OSAS only. As 
a result, their ventricular function and structure were less abnormal at baseline when 
compared to the treatment group. This hindered the detection of the real treatment 
effect and also the investigation of the persistence of the ventricular abnormalities in 
untreated childhood OSAS. A proportion of OSAS children and the control group did 
not return for repeat assessment at 6 months. On further analysis, there were no 
significant differences in anthropometric, PSG and ECHO measurements between 
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those who did not return and the non-treatment group. Nonetheless, our study has the 
advantage of a normal control group for comparison at baseline and a non-treatment 
group returning for repeat assessment. 
5.5 Conclusion 
OSAS is prevalent and can be unnoticed in school children resulting in RV and 
LV remodeling and dysfunction. Community based screening programme may allow 
early detection and treatment of OSAS that could potentially reverse myocardial 






The results from this population-based study will certainly enrich the scanty 
world literature on the cardiovascular complication of childhood OSAS. Our study 
provided evidence that OSAS is an independent risk factor for hypertension in 
children, and the condition also causes cardiac dysfunction and remodeling which 
can be reversed after treatment for OSAS. At a practical level, paediatricians and the 
public should be made more aware of the potential long-term implications of 
childhood OSAS and the importance of early diagnosis and treatment. 
Based on the cross-sectional design of this study, definite conclusion on the 
relationship between childhood OSAS and cardiovascular diseases could not be 
drawn. Longitudinal study is required to further confirm the pathological role of 
OSAS on various cardiovascular diseases. Furthermore, in order to understand the 
whole picture, it is worthwhile investigating the mechanisms linking cardiovascular 










電話: 塡寫日期 :—/—/— 
(曰/月/年） 
主要資料來源提供者： 
1 • 父 親 2 • 母 親 3 • 近 親 （ ) 4•其他： 











1)性別： 1•男 2•女 
2) a.出生日期(日/月/年）： / / 
b.出生地點：1口香港2口中國（在港居住年期：一年一月）3口其他（在港居住年期：―年一月） 
C.名字(英文）： 
3) a .身高： (厘米） b . *體重： (千克/膀）請刪去不適用者} 
4)居住情況：（可“Z”多項選擇） 




a . 年 級 ： (請塡上現時就讀的班級） 
b . 時間： 1 0 上午班 下午班 3•全曰 
(B)兒童在『最近一年』內的睡眠狀況 
6)這兒童通常都是自己睡一間房嗎? 
!•是 不是（和 同睡一間房） 
7)他/她通常都是自己睡一張床嗎? 
!•是 （)•不是（和 同睡一間床） 
8) a.i.星期一至五,他/她每晚通常甚麼時候上床睡覺? 時:__分 
11.星期一至五，他/她每天通常甚麼時候起床? 時:___分 
b.i.星期六、日不用上學的時候,他/她每晚通常甚麼時候上床睡覺? 時 :一分 
11.星期六、日不用上學的時候,他/她每天通常甚麼時候起床? 時 : _ _分 
c.i.在長假期或暑假裡,他/她每晚逋常甚麼時候上床睡覺? 時 :一分 
11.在長假期或暑假裡,他/她每天通常甚麼時候起床? 時 : _ _分 
9) 他/她通常需要多少時間才能入睡? 
!•少於10分鐘 2口 11-30分鐘 3口 31-60分鐘 4口超過60分鐘 
10)他/她最近一年內平均每晚睡多少時 間 小時 分鐘 
11) a.你認爲術她得到足夠的睡眠嗎? 丨口足夠 0 O不足夠 




從不 每月 每月 每週 每週 不清楚 
少於一次一至兩次一至兩次三次或 
以上 
12)晚上難以入睡 o n !• 2 0 3 0 4 0 5 0 
13)將入睡時，感到憂慮或恐懼 o n !• 2 0 3 0 4 0 5 0 
14)將入睡時，頭部重覆地搖動或碰撞 o n !• 2 0 3 0 4 0 5 0 
15)睡覺時，手或腳經常不隨意地抽搐或跳動 o n !• 2 0 3 0 4 n 5 n 
16)睡覺時經常流汗 O O 1 0 2 0 3 0 4 0 s n 
17)睡至半夜會“扎”醒 O O ；!• 2口 3 0 4 0 5 0 
18)睡覺時呼吸困難 OO l O 2 0 3 0 4 0 5 0 
19)睡覺時用口呼吸 O O 1 0 2 0 3 0 4 0 5 0 
20)睡覺時短暫性地停止呼吸（至少有幾秒鐘） C O ! • 2 0 3 0 4 0 5 0 
21)睡覺時試過咀唇變藍 O O l O 2 0 3 0 4 0 5 0 
22)睡覺時，經常『反瞓』（即經常轉身） 0口 1口 2口 3口 4口 5口 
23)以特殊『俯睡』的姿勢睡覺（即肌啦度瞓， 0口 1口 2口 3口 4口 5口 
24)睡覺時『磨牙』 （)• l O 2 0 3 0 4 0 S D 
25)睡覺時『瀨尿』 （)• l O 2 0 3 0 d 5 0 
26)睡覺時『發開口夢』 （)• 1 0 2 0 3 0 4 0 5 0 
27)睡覺時發惡夢 （)• : 0 2 0 3 0 4口 5 0 
28)早上太早醒來後（如天還沒亮)，便不能再 o n 1 口 2口 3口 4口 5口 
29)早上起床後，覺得口乾 l O 2 0 3 0 4 0 5口 
30)早上很不願意起床 （)• 1 0 2 0 3 0 4 0 5 0 
31)早上起床後，覺得好像沒有休息過 C O l o 2 0 3 n 4 n s n 
32)早上起床後，覺得頭痛 O O l O 2 0 3 0 4 0 5口 
33)白天裡，覺得好疲倦 o n !• 2口 3 0 4 0 5 0 
34) a.在過往一年內，他/她有沒有打鼻軒呢? 
on從不（跳至3 5題） 10每月少於一晚 2口每月有一至兩晚 
30每週有一至兩晚 40每週有三晚或以上 50不清楚(跳至35題） 
b.鼻鼾聲有幾嚴重？ 
!•輕微 2 0 —般 3 0 嚴 重 4 0非常嚴重 
35) a.在過往一年內，他/她睡著後,有沒有突然間尖叫或驚恐，你嘗試叫醒他/她，卻好像沒有 
反應。當他/她睡醒後，對昨晚發生的事卻完全沒有印象？ 
••沒有（跳至36題） 10每月少於一晚 2 0 —個月一至兩晚 





o n 沒有（跳至 3 7 題） 1 0 每月少於一晚 2 0 —個月一至兩晚 
3 0 —週有一至兩晚 4 0 —週有三晚或以上50不清楚(跳至37題） 
b.「夢遊」的情況通常發生 1口睡了不久 2口睡到半夜 3口醒之前 4口整晚 
C.請形容一下「夢遊」的情況： 
d.「夢遊」時有沒有弄傷自己或其他人? o n 沒 有 1 •有 
e.幾多歲開始呢？ 
37 a.白天裡,他/她有沒有小睡（_晏覺/午睡)的習慣呢? 
o n 不需要（跳至 3 8 題） 1 0想，但不能睡著（跳至3 8題） 
2 0每週有一至兩天 3 0每週有三至五天 
4 0每天或差不多每天都有 5 0不清楚（跳至 3 8題） 
b.他/她通常會睡多少時間？ 
!•少於15分鐘 2 0 16至30分鐘 3 0 31至60分鐘 
4 0 61至120分鐘 50超過120分鐘（約: 分鐘） 
38)白天裡，他/她有沒有在以下的情況下突然睡著呢？ 




進 食 時 — -
看 電 視 時 ~ ~ 一 — 
I 上課時 I I I I I I 丨 
39) a.晚上睡覺時，家裡環境如何？ 0 0 不嘈吵 1 0有點嘈吵 2 0 非常嘈吵 
40) a. 除了以上所提及，他/她還有其他睡眠問題嗎？ 0 0 沒 有 1 口 有 （ 請 列 出 ： _ _ ) 
b. i.家人當中有沒有任何睡眠問題呢？ 00沒有10有（請答b.ii.題） 
ii.如有，請列出問題(可“力’多項選擇）： !•經常打鼻軒（家人： ) 
2•經常失眠 （家人： ) 
3口其他： (家人： ) 
( C ) 兒 童 • 活 爾 
41)他/她每日平均花多少時間在以下的活動裡? 
a.上課: 小時—分鐘 b.溫習、做功課：—小時__分鐘 C.看電視：—小時—分鐘 




1口溫習、做功課 2口看電視 3口運動 4口講電話 5口進食 
6口看課外書籍 7口玩電子遊戲 8口用電腦或上網 9口其他: 
XXV 
Appendix 
43) a.你認爲他/她是否比同年齡的孩子過度活躍呢? o n 否 !•是 
b.他/她是否經常發脾氣或情緒難以控制？ 0 •否 1•是 
C.與上一個學年比較，他/她在學習上的成績表現是怎樣? 
!•非常差 2 0 較 差 3 0差不多 4 0 較 好 5 0非常好 
44) a.最近一年內，他/她的健康狀况是怎樣呢? 1口非常差2口差3口普通 4•好5口非常好 
b.最近一年內，他/她有沒有長期服食藥物? on沒有 1口有（請列明: ) 
45)最近一年內，他/她有沒有患上： 
生碰离.............i^oQ...逸直—...�1Q..M"—....生嫂 Id.薩..............I..1.S...M41.S...H................... 
b.|Lfj^? jog薩—... . . . . . . . . . . . .bnjf f ⑶煙！?.....ta....逸直..............|i.P..,M£..............•赏 
|c.中耳炎？ | o • 沒 有 — I D 間 中 b • 經 常 If.喉兔發炎？ I c q 沒 有 [ i d 間 中 | 2口經常 
46)他/她有沒有患上以下這些疾病並需要接受治療?(可多項選擇） 
o n 沒 有 1 0 過於肥胖 2 0 眼 疾 3 0膽固醇過高 
4 0關節炎 5 0癲癇症 6 0心臟病 7 0癌症（ ) 
8 0糖尿病 9 0長期肺病 1 0 0濕疼 1 1 0精神病 
120地中海貧血病 1 3 0遺傳病 ( ) 14口其他: 
47) a.他/她是否足月出世？ （ 0 否 （ 出 世 時 : — 週 ） ! • 是 
b.他/她是否以母乳餓養？ 0•否 1 • 是 （ 約 維 持 月 ） 




1.年齡： l i . 職業： !•無業 2 0 工人 3 0 文員 4 0 專業人員 5 •其他： 
111.教育程度(最高學歷)：!•無20小學30初中40高中5•大學或以上 
b.母親 
1.年齡： 1 1 .職業： !•無業 2口工人 3 0文員 4 0專業人員 5•其他： 
h i .教育程度 (最高學歷 )： !•無 2 0小學 3 0初中 4 0高中 5•大學或以上 
50)父母的婚姻狀況：!•同居 已婚 3 0 離 婚 4 0 mm 5 0 未 婚 
51) a .有沒有人在家裡吸煙？ 0 0 沒 有 1口間中 2口經常 
b.家裡有沒有飼養寵物？ 0•沒有 1•有（種類： 飼養年期：一年一月） 
52)住所類型： 
!•公屋 2 0 居 屋 3 0私人樓宇 40木屋/臨屋 5•村屋 6•其他： 
53)居住面積： 
1 口 200平方卩尺或以下 2 口 201-400平方卩尺 3 口 401-600平方卩尺 4 口 601-800平方口尺 
5 n 801-1，000平方沢 6 0 1，001平方吸以上 
54)家庭每月總收入： 
! • HK$5，000或以下 2 口 HK$5,001-10,000 3 口 HK$ 10,001-15,000 4 口 HK$ 15,001-20,000 
5 n HK$20,001-60,000 6 口 HK$60，0(n或以上 7•領取綜援金(約: ) 8•不定（約 : ) 
xxi 
Appendix 
)………))………y-rT vr-r/."…；.,々,/ 々/丨，,'"71""'| y… 
APPENDIX 
Hong Kong Children Sleep Questionnaire (Li AM. et al. 2006) 
Hong Kong Children Sleep Questionnaire 
Name: Serial No.: 
(For official use only) 
Telephone: Date of completion: _ _ / _ _ / (dd/mm/yyyy) 
Informants: 
! • Father 2口 Mother 3口 Relatives ( ) 4口 Others ( ) 
氺氺氺氺氺氺氺氺氺氺氺氺氺氺氺氺氺氺氺He氺氺氺氺本氺氺氺木氺氺H；氺氺氺氺氺氺*氺氺氺氺氺氺氺氺氺氺氺氺氺;i；氺氺氺;i；氺氺氺氺氺;i；氺氺氺*氺氺氺;i；氺氺 
The Departments of Paediatrics and Psychiatry from the Chinese University of Hong Kong are 
conducting a Sleep Assessment Study on Hong Kong Chinese Children. 
W e would like to invite parents of children aged 6 to 13 years to provide information relating to their 
children's sleep behaviour over the past twelve months. 
If you are not sure of the child's sleep behaviour, you could consult with the other family members 
for sivins the response that best describes the condition. 
*This is a 5-page 54-item questionnaire, please give a " V " in the appropriate box, and answer all 
questions. Thank you for your kind cooperation. 
*** All provided information is for research purpose only，under strict confidential *** 
xxii 
Appendix 
(A) Personal information of the child: 
1)Sex: ! • Male 2口 Female 
2) a. Date of Birth(dd/ mm/yy): / / 
b. Birth Place: ! • Hong Kong (HK) 2口 China 3 • Others 
(year of residence in HK: _year—month) 
c. Engl ish N a m e : 
3) a. Body Heig ht: (cm) 
b. Body Weight: (kg / pound)* { *Please delete if inappropriate} 
4) Li ving condition: (Response can be more than one) 
a. 1 • with parents 2 0 with father 3 0 with mother 4 0 with relatives 5 0 Others: 
b. No. of household members living together (included this child): 
c. No. of siblin gs: 
5) Education: 
a. Level: (Class) 
b. Session: i D A M P M 3 • Whole day 
(B) Sleep behaviour in the vast 12 months: 
6) Does your child sleep in his/her own room? 
I d Yes O D N o (sleep with ) 
7) Does he/she sleep in his/her own bed alone? 
! • Yes o n N o (sleep with ) 
8) a.i. When does he/she usually go to bed during weekday si hr: min 
ii. When does he/she usually get up during weekdays? hr: min 
b.i. When does he/she usually go to bed during weekends? hr: min 
ii. When does he/she usually get up during weekends? hr: min 
c.i. When does he/she usually go to bed during school holidays hr: min 
ii. When does he/she usually get up during school holidays? hr: min 
9) H o w quickly does he/she usually fall asleep? 
! • <10mins 2口 11-30 mins 3口 31-60 mins 4口 >60 mins 
10) What is his/her average sleep duration? hr min 
11) a. Do you think he/she have enough sleep? 1 口 enough 0口 not enough 
b. H o w many hours do you think is adequate for your child? hr min 
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For each question below, please tick the appropriate box that best describes how often each symptom or 
problem has occurred during the past 12 months. 
<lx l-2x l-2x >3x Don't 
er (/month) (/month) (/week) (/week) know 
12) difficulty in falling asleep in the evening? OD 2口 3口 4口 5EJ 
13) felt anxiety just before falling asleep? OD i D 2口 3口 4口 5口 
14) repetitive rocking movements or headbanding while 力门 《门 
falling asleep? ^ ^ 2 U 3 U 4 U 5 U 
15) startled or jerky movements of body parts while „ „ j—, ^门 
asleep? OU l U 2 U 幻 4 U ^ U 
16) sweating frequently during the night? OD i D 2口 3口 4口 5口 
17) sudden night awakening during sleep? OD ! • 2口 3口 4口 5口 
18) breathing difficulty during sleep? OD ! • 2 0 3 0 4 0 S D 
19) mouth breathing during sleep? OD O 2口 3口 4口 5口 
20) breath holds or pauses during sleep? OD I D 2口 3口 4口 5口 
21) lips turning blue while asleep? OD O 2口 3口 4口 5口 
22) frequent position change while asleep OD O 2 D 3口 4口 5口 
23) sleep in prone position with buttocks up and neck •口 1口 2口 3口 4口 5口 
Gxtcndcd 
24) teeth grinding during sleep? OD O 2口 3口 4口 5口 
25) bed wetting during sleep? 0口 O 2口 3口 4口 5口 
26) sleep talking? OD i D 2 0 3 0 4 0 5 0 
27) nightmares? OD i D 2 0 S D 4 0 5 0 
28) early morning awakening, and could not fall asleep 门 门 门 n cm 
again? l U 2 U 4 U ^ U 
29) dry mouth in the morning? OD O 2口 3口 4口 5口 
30) difficulty getting out of bed in the morning? 1口 2口 3口 4口 5口 
31) unfreshed after waking up in the morning? 0口 1口 2口 3口 4口 5口 
32) headache after waking up in the morning? 0口 1口 2口 3口 4口 5口 
33) felt tired during the day? OD ! • 2 0 3口 4口 5 0 
34) a. Ho w often did he/she snore? 
o n never (go to 35) 1 口 less than o ne night per month 2口 1 -2 nights per month 
3口 1 -2 nights per week 4口 more tha n 3 nights per week 5口 d on't know (go to 35) 
b. How loud was his/her snoring? 
I D slight 2 n mild 3口 severe 4口 very severe 
35) a. Did he/she suddenly scream out or appear confused that you cannot seem to get his/her response, 
but did not have memory of these events the next morning? 
o n never (go to 35) ! • less than o ne night per month 2 0 1 -2 nights per month 
3 n 1 -2 nights per week 4口 more tha n 3 nights per week 5口 d on't know (go to 35) 
b. What was the age of onset? 
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36) a. Did he/s he sleepwalk (get up from the bed and walk)? 
o n never (go to 35) ! • less than o ne night per month 2\Z\ 1 -2 nights per month 
3口 1 -2 nights per week 4口 more tha n 3 nights per week 5口 d on't know (go to 35) 
b. When did it usually happen? 
1 口 shortly after sleep 2口 midnight 3口 before wake up 4口 throughout the night 
c. Give description on sleepwalking: 
d. Did he/she get hurt or injure anyone? O D N o l O Yes 
e. What was the age of onset? 
37 a. Did he/s he sleep during the day (Take naps)l 
o n N o need (go to 38) ! • Wanted but cannot sleep (go to 38) 
2口 Twice weekly or less 3 D On 3-5 days weekly 
4口 Daily or almost daily 5口 Don't know (go to 38) 
b. H o w long did he/she usually sleep? 
! • <15mins 2口 16-30 mins 3 0 31-60 mins 4口 61-120 mins 
5口 >120 mins (estimated mins: ) 
38) Did he/she fall asleep unintentionally during the day while he/she was ？ 
Never Monthly or Monthly Weekly Daily Several 
less times daily 
Reading ()• O 3口 4 0 5 0 
Traveling ()• O 2 0 3 0 4口 5 0 
Standing O D ! • 2 0 S D 4 0 S D 
Eating o n I D 2 0 3 0 4口 S D 
Watching television ()• \\J 2口 3口 4口 5口 
Attending lesson ()• ! • 2口 3口 4口 5口 
39) a. Ho w noisy was the sleep environment? 0口 not noisy 1 口 little noisy 2口 noisy 
40) a. Did he/she have any other sleep problem? O D no ! • yes ( ) 
b. i. Did any family member have sleep problem? 0口 no 1 口 yes (please answer 40b.ii.) 
ii. If yes, please list out: 1口 frequent snore ( ) 
(Response can be more than one) 2 0 frequent insomnia ( ) 
3口 others: ( ) 
(C) Daily activities and health conditions: 
41) What was the average time that he/she took for the following daily activities? 
a. Class: —hr —min b. Homework: —hr —min c. TV: —hr 一min 
d. Telephone: —hr 一min e. Reading: 一hr —min f. Sport: —hr —min 
g. Electronic game: 一hr —min h. Computer/ Internet: —hr —min i. Transport: 一hr 一min 
j. Other extra-curriculum activities (e.g. playing piano, drawing, exclude sport): 一hr 一min 
42) What did he/she usually do at one hour before going to beet? (Response can be more than one) 
! • Homework 2 0 T V 3口 Sport 4 0 Telephone S D Eating 
6 0 Reading Electronic S Q Computer/ Internet 9 0 Others: 
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43) a. Did you think that he/she was hyperactive compared to others? ()• N o i D Yes 
b. Does he/she lose his/her temper frequently? ()• N o ! • Yes 
c. What was his/her study performance compared with last academic year? 
1 口 much worse 2口 worse 3口 similar 4口 better 5口 much better 
44) a. What was his/her health condition? 
1 口 very poor 2口 poor 3口 genera丨 4口 good 5口 very good 
b. Was he/she on long term medication? O D N o ! • Yes (Please list out: ) 
45) Did he/she suffer from the following diseases? 
iO.D N o | I D Sometimes 2[J 
芬? [OQ No l i p .Sometimes 2Q frequently 
iO.D No jlQ ；专 l2Q frequently 
尘 [0.n No I]口 ！？迎？j；迪 1.?口 frequently 
e. Tonsillitis? lOH N o llD Sometimes ；20 frequently 
r…… I i 
If. Laryngopahrygngitis iOD No !lD Sometimes 丨2口 frequently 
46) Has he/she ever been diagnosed and treated for the following diseases? (>1 box(es) can be ticked) 
O D no 1 口 obesity 2口 eye disease 3口 hyper cholesterol 
4口 arthritis 5口 epilepsy 6口 heart disease 7口 cancer ( ) 
S D mellitus diabetes 9 0 chronic lung disease l O D eczema l l D psychiatric disease 
1 2 0 thalassaemia \3\Z\ inherited disease 1 4 0 others: 
47) a. W as he/she a full term baby? 〇• no (gestation week: ) ! • yes 
b. Did he/she have breast feeding? 〇• no ! • yes ( month) 
48) If necessary, would you like us to offer a sleep assessment and health checkup to him/her? 
! • Yes o n N o 
(D) Family information: 
49) Parental information: 
a. Father i. Age: ii. Occupation: iii. Education level (highest): 
b. Mother i. Age: ii. Occupation: iii. Education level (highest): 
50) Parental marriage: 1口 co-habited 2口 married 3口 divorced 4口 widowered/widowed 
5口 single 
51) a. Did anyone smoke in the home? 0口 no 1 口 sometimes 2口 frequent 
b. Are there pets at home? 0口 no 1 口 yes (type: -- rearing period: _ y r 一month 
52) Accommodation: 
1 口 public rental housing 2口 home ownership scheme 3口 private 4口 wooden/temporary 
5口 village 6口 Others: 
53) House size (square metered feet): 
I D <200 2 n 201-400 3 0 401-600 
4 n 601-800 S D 801-1,000 6 0 >1,001 
54) Household monthly income (HK$): 
!• <5,000 2口 5,001-10,000 3口 10,001-15,000 4口 15,001-20,000 5口 20,001-60,000 
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